data_2jzo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jzo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.506 ' HB ' ' HG2' ' A' ' 105' ' ' ARG . 75.0 p . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 121.165 0.507 . . . . 0.91000000000000003 110.931 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.61 ' O ' ' HD2' ' A' ' 105' ' ' ARG . 47.2 mt -71.53 136.24 26.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.658 -1.978 . . . . 0.80000000000000004 105.658 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.93 144.72 36.6 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-N 115.246 -0.888 . . . . 0.68999999999999995 110.557 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.532 HD12 HG23 ' A' ' 101' ' ' THR . 41.5 mt -126.59 130.91 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.388 -0.968 . . . . 0.56000000000000005 108.388 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.4 t -125.07 128.82 73.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 105.71 -1.959 . . . . 0.53000000000000003 105.71 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.2 mt -108.69 132.72 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.24 -0.652 . . . . 0.35999999999999999 109.24 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.81 134.17 6.8 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 120.036 -1.078 . . . . 0.34000000000000002 111.093 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.501 HG22 ' N ' ' A' ' 14' ' ' ALA . 14.4 t -142.13 165.72 26.68 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.101 -1.444 . . . . 1.0700000000000001 107.101 177.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.599 ' ND1' ' OD2' ' A' ' 67' ' ' ASP . 72.9 m80 -68.58 151.95 46.05 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 102.343 -3.206 . . . . 2.3399999999999999 102.343 174.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.32 -148.14 40.25 Favored Glycine 0 C--N 1.307 -1.03 0 C-N-CA 117.174 -2.441 . . . . 0.46999999999999997 113.954 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -120.88 26.32 9.15 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.341 1.238 . . . . 0.87 114.341 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.99 -26.93 43.32 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.945 1.461 . . . . 0.28000000000000003 114.945 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.501 ' N ' HG22 ' A' ' 9' ' ' THR . . . -55.36 -46.21 76.47 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.051 0.842 . . . . 0.29999999999999999 112.321 -176.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -60.0 -40.15 88.25 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.583 -0.447 . . . . 0.55000000000000004 110.892 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -71.36 -34.19 70.24 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.325 0.861 . . . . 0.5 113.325 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.38 -38.77 91.03 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 106.719 -1.586 . . . . 0.34000000000000002 106.719 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.1 tp -66.29 -43.84 85.18 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.5 -0.926 . . . . 0.5 108.5 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.678 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 24.3 mttm -60.99 -38.99 87.97 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 120.865 0.364 . . . . 0.60999999999999999 111.101 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.6 m -64.53 -46.91 80.83 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 108.289 -1.004 . . . . 0.54000000000000004 108.289 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.83 -44.24 90.86 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 119.898 -0.721 . . . . 0.60999999999999999 110.755 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.877 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -68.46 -22.7 64.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.416 -0.356 . . . . 2.4199999999999999 110.42 -178.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.498 ' HE2' ' O ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -71.1 -32.31 68.87 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.447 -2.057 . . . . 2.1699999999999999 105.447 178.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.1 mt -84.32 -39.03 19.65 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.459 0.911 . . . . 1.29 113.459 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.444 HD13 HG12 ' A' ' 99' ' ' VAL . 96.1 mt -109.1 -11.9 14.88 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 118.568 2.803 . . . . 1.3300000000000001 118.568 -175.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.42 165.64 30.93 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 105.21 -3.156 . . . . 0.84999999999999998 105.21 -175.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -59.96 138.8 57.75 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.59 1.186 . . . . 0.87 112.162 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -105.53 147.12 28.71 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 112.874 -1.966 . . . . 0.76000000000000001 112.901 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -106.15 158.46 16.82 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 113.949 -1.478 . . . . 0.94999999999999996 107.537 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.7 t30 57.42 42.07 25.27 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.73 -1.123 . . . . 0.76000000000000001 113.951 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.7 t -131.12 135.01 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.053 -1.092 . . . . 0.63 108.053 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.86 168.14 19.11 Favored Glycine 0 N--CA 1.476 1.307 0 N-CA-C 109.428 -1.469 . . . . 0.53000000000000003 109.428 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -156.15 158.64 38.0 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 121.75 -0.853 . . . . 0.56000000000000005 108.699 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 pt -137.68 160.03 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 115.416 -0.811 . . . . 0.54000000000000004 109.454 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -115.06 163.41 15.65 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 108.533 -0.914 . . . . 0.57999999999999996 108.533 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.429 ' CD1' ' C ' ' A' ' 36' ' ' PHE . 1.6 t80 -134.87 116.86 15.24 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 106.627 -1.619 . . . . 0.69999999999999996 106.627 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.9 t -107.78 145.59 31.66 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 113.845 -1.525 . . . . 0.77000000000000002 110.581 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -56.6 134.92 67.43 Favored 'Trans proline' 0 C--N 1.345 0.378 0 N-CA-C 108.292 -1.465 . . . . 0.83999999999999997 108.292 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.46 -25.42 15.46 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.406 -1.478 . . . . 0.93999999999999995 109.406 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -84.64 158.35 20.88 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.597 0.713 . . . . 0.85999999999999999 109.611 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 50.8 p30 -125.89 179.47 5.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.937 -1.135 . . . . 2.9300000000000002 107.937 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.84 -34.69 73.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.495 0.554 . . . . 0.81999999999999995 112.495 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -65.48 -36.17 83.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.281 0.562 . . . . 2.9300000000000002 111.681 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.4 m -63.66 -47.64 80.45 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.993 -1.855 . . . . 0.87 105.993 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.59 -36.37 83.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.186 -0.605 . . . . 0.73999999999999999 112.433 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.9 -42.76 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.971 -1.122 . . . . 0.84999999999999998 107.971 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -62.83 -42.55 99.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 120.014 -0.675 . . . . 0.93999999999999995 110.381 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -62.45 -42.99 99.86 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 119.342 -0.943 . . . . 0.72999999999999998 110.839 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -62.63 -45.4 93.0 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 108.677 -0.86 . . . . 0.66000000000000003 108.677 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -60.71 -39.78 89.82 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.46 0.541 . . . . 0.85999999999999999 112.46 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.82 79.34 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.344 -0.542 . . . . 0.81999999999999995 109.829 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -71.06 -43.72 67.23 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 119.594 -0.842 . . . . 0.68999999999999995 109.451 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.1 mt -60.0 -37.7 80.48 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 116.511 -0.313 . . . . 0.77000000000000002 111.587 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.74 -25.8 29.98 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.222 0.453 . . . . 0.90000000000000002 112.222 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -96.25 -4.68 41.9 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.04 -0.527 . . . . 0.84999999999999998 112.394 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -105.61 158.64 16.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.714 0.635 . . . . 0.81000000000000005 112.714 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -90.47 107.43 19.15 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 102.39 -3.189 . . . . 0.92000000000000004 102.39 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -106.41 14.99 26.59 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 124.203 0.94 . . . . 0.82999999999999996 110.842 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.3 p -63.71 -33.86 76.57 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 115.172 1.545 . . . . 1.01 115.172 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -92.81 -8.84 42.46 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 123.335 0.397 . . . . 1.05 111.463 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.67 172.03 12.98 Favored Glycine 0 C--N 1.314 -0.641 0 C-N-CA 119.351 -1.404 . . . . 0.80000000000000004 112.892 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.1 t -139.04 130.86 36.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.004 0 N-CA-C 109.11 -0.7 . . . . 0.69999999999999996 109.11 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.586 ' HG ' HD22 ' A' ' 65' ' ' LEU . 29.6 tp -116.57 114.99 24.9 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 125.323 1.64 . . . . 0.57999999999999996 107.524 177.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -92.6 122.41 34.99 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 105.642 -1.984 . . . . 0.59999999999999998 105.642 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.586 HD22 ' HG ' ' A' ' 63' ' ' LEU . 82.8 mt -109.72 114.99 29.03 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 104.644 -2.354 . . . . 0.42999999999999999 104.644 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.406 HG21 ' HA ' ' A' ' 91' ' ' ALA . 27.4 m -120.06 163.71 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 121.706 0.765 . . . . 0.40000000000000002 112.821 -176.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.599 ' OD2' ' ND1' ' A' ' 10' ' ' HIS . 12.1 p-10 -65.51 -54.66 24.98 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 117.117 2.266 . . . . 0.33000000000000002 117.117 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.3 p -141.48 151.49 43.38 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 122.633 1.206 . . . . 1.1200000000000001 112.652 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -65.86 134.36 52.87 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.791 -1.55 . . . . 0.76000000000000001 108.013 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.85 -7.12 75.82 Favored Glycine 0 N--CA 1.468 0.781 0 N-CA-C 120.092 2.797 . . . . 0.67000000000000004 120.092 176.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.36 174.83 55.0 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 119.686 1.743 . . . . 0.59999999999999998 109.313 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.499 ' HB2' ' HD3' ' A' ' 73' ' ' PRO . 33.3 m -57.64 -47.22 99.34 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 122.185 -0.597 . . . . 1.8300000000000001 111.734 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.499 ' HD3' ' HB2' ' A' ' 72' ' ' SER . 85.2 Cg_exo -53.75 -41.76 71.7 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 N-CA-C 110.351 -0.673 . . . . 0.51000000000000001 110.351 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -67.42 -48.67 66.64 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.531 0.519 . . . . 0.70999999999999996 109.645 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.96 -42.47 94.14 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.648 0.981 . . . . 2.6000000000000001 113.648 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.97 -42.9 84.36 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.366 -0.933 . . . . 0.69999999999999996 111.232 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.97 -38.19 90.14 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.531 -0.914 . . . . 0.63 108.531 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.635 ' O ' HG12 ' A' ' 82' ' ' VAL . 4.0 m -59.33 -38.69 80.95 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.16 0.43 . . . . 1.96 112.16 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.633 ' O ' HG21 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -68.78 -29.25 67.59 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.548 -0.461 . . . . 3.9199999999999999 112.022 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.403 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 73.0 mt -77.25 -43.1 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 111.91 0.337 . . . . 0.78000000000000003 111.91 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 87' ' ' TYR . 2.5 m -78.89 -17.52 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 115.441 1.645 . . . . 0.80000000000000004 115.441 -175.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 78' ' ' SER . 30.5 m -29.09 -55.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 121.397 3.851 . . . . 1.4299999999999999 121.397 -176.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.09 38.96 4.04 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 116.701 -2.0 . . . . 1.03 108.947 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.403 ' HD3' ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -112.48 133.74 54.39 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.613 -1.176 . . . . 0.90000000000000002 109.479 -179.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -78.65 141.6 37.85 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 106.674 -1.602 . . . . 1.03 106.674 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 61.1 m170 62.43 35.33 14.9 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 114.386 1.254 . . . . 0.97999999999999998 114.386 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.487 ' HB3' ' HB ' ' A' ' 81' ' ' VAL . 6.2 m-85 -128.63 129.88 46.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 105.25 -2.13 . . . . 0.79000000000000004 105.25 175.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -145.49 156.26 43.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.173 -0.611 . . . . 0.69999999999999996 110.226 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.3 t -122.67 128.76 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 N-CA-C 105.623 -1.991 . . . . 0.59999999999999998 105.623 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.533 HD11 HD11 ' A' ' 63' ' ' LEU . 34.1 mt -124.73 120.77 59.67 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 N-CA-C 107.496 -1.298 . . . . 0.56999999999999995 107.496 177.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.406 ' HA ' HG21 ' A' ' 66' ' ' VAL . . . -86.33 164.16 17.25 Favored 'General case' 0 CA--C 1.571 1.772 0 CA-C-N 114.571 -1.195 . . . . 0.47999999999999998 111.095 177.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.19 24.45 57.24 Favored Glycine 0 C--O 1.222 -0.639 0 CA-C-N 115.684 -0.689 . . . . 0.39000000000000001 114.512 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.8 p -48.64 132.88 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 112.91 0.707 . . . . 0.29999999999999999 112.91 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.577 ' HB3' ' HB3' ' B' ' 94' ' ' ASN . 52.4 p30 -142.11 170.24 16.09 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.512 -1.292 . . . . 0.47999999999999998 107.512 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.8 mm -61.64 -42.68 85.03 Favored Pre-proline 0 C--O 1.243 0.734 0 N-CA-C 113.771 1.026 . . . . 1.1399999999999999 113.771 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' A' ' 94' ' ' ASN . 24.9 Cg_exo -57.06 -43.82 50.11 Favored 'Trans proline' 0 CA--C 1.552 1.403 0 CA-C-N 119.732 0.94 . . . . 0.65000000000000002 110.113 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 40.4 ttm -61.4 -48.88 79.19 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 120.177 -0.609 . . . . 0.52000000000000002 109.642 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.6 tp -61.18 -47.52 85.78 Favored 'General case' 0 C--O 1.203 -1.349 0 C-N-CA 120.344 -0.543 . . . . 0.52000000000000002 112.118 -177.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.444 HG12 HD13 ' A' ' 25' ' ' LEU . 85.9 t -62.37 -49.25 84.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 112.36 0.504 . . . . 1.28 112.36 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.76 ' CA ' ' OE1' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -63.93 -40.9 97.53 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.256 -0.577 . . . . 2.0499999999999998 111.213 -179.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.532 HG23 HD12 ' A' ' 5' ' ' ILE . 53.5 m -65.94 -45.7 80.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.825 -0.625 . . . . 0.67000000000000004 110.89 -178.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.6 mt -65.25 -37.49 87.4 Favored 'General case' 0 CA--C 1.551 1.0 0 O-C-N 123.518 0.511 . . . . 0.73999999999999999 110.018 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.475 ' HB2' ' HE2' ' A' ' 103' ' ' MET . 3.0 mtp -66.32 -45.92 78.62 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.429 -0.794 . . . . 1.6499999999999999 111.699 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.69 75.38 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.897 0.703 . . . . 1.3300000000000001 112.897 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.61 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 17.6 ttp180 -53.03 -32.9 49.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.873 -0.603 . . . . 0.85999999999999999 112.599 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.19 -19.8 61.03 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 113.598 0.962 . . . . 2.3500000000000001 113.598 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -90.61 18.23 6.59 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 121.906 0.86 . . . . 2.2799999999999998 109.302 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.9 t70 46.82 59.2 16.48 Favored Pre-proline 0 C--N 1.313 -1.009 0 N-CA-C 116.174 1.916 . . . . 1.0600000000000001 116.174 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.8 168.92 23.59 Favored 'Trans proline' 0 C--O 1.207 -1.048 0 C-N-CA 120.966 1.111 . . . . 0.98999999999999999 110.432 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.513 ' HG ' ' CG ' ' A' ' 113' ' ' GLU . 54.7 p -78.05 163.12 26.19 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 106.245 -1.761 . . . . 1.02 106.245 175.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -56.66 -51.32 69.17 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-O 119.105 -0.474 . . . . 0.90000000000000002 111.83 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -59.15 -36.29 75.01 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.784 0.72 . . . . 0.96999999999999997 112.607 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.513 ' CG ' ' HG ' ' A' ' 110' ' ' SER . 87.9 mt-10 -64.74 -45.81 84.9 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.4 -0.593 . . . . 1.0700000000000001 109.4 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 15.6 tp -65.33 -45.07 85.73 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 120.757 -0.377 . . . . 0.81999999999999995 110.728 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.78 -47.8 85.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.335 -0.546 . . . . 0.75 109.962 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.67 -43.23 97.92 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 120.878 0.371 . . . . 0.85999999999999999 111.944 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.403 HD11 HG21 ' A' ' 121' ' ' THR . 54.9 tp -63.76 -42.31 97.83 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 119.495 -0.288 . . . . 1.3400000000000001 110.376 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.78 -44.39 96.85 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.831 -0.748 . . . . 0.67000000000000004 111.861 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.43 -46.32 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 109.295 -0.632 . . . . 0.71999999999999997 109.295 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -63.58 -45.58 89.78 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.06 0.763 . . . . 0.93000000000000005 113.06 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.403 HG21 HD11 ' A' ' 117' ' ' LEU . 57.6 p -71.79 -31.5 66.66 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 120.335 -0.546 . . . . 1.29 111.701 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.12 -45.83 94.58 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 108.795 -1.722 . . . . 0.59999999999999998 108.795 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.5 mtp-105 -72.63 -41.7 65.22 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.228 0.455 . . . . 0.84999999999999998 112.228 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -70.65 -19.86 62.77 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.536 -0.866 . . . . 2.54 111.502 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.42 -16.33 77.36 Favored Glycine 0 CA--C 1.535 1.29 0 O-C-N 124.041 0.838 . . . . 0.68000000000000005 112.826 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.454 HG13 ' CE ' ' B' ' 97' ' ' MET . 94.0 t -89.73 111.59 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 106.452 -1.684 . . . . 0.73999999999999999 106.452 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -154.66 138.1 15.88 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.835 -0.802 . . . . 3.25 108.835 -173.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.33 147.53 23.4 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.044 0.926 . . . . 1.3500000000000001 109.494 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 130' ' ' LYS . 41.8 tp -67.81 -57.94 5.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.071 -0.968 . . . . 1.48 110.7 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 129' ' ' LEU . 76.0 mttt . . . . . 1 C--O 1.433 10.715 1 CA-C-O 145.741 12.21 . . . . 3.21 110.634 177.727 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' THR . . . . . 0.487 ' HB ' ' HG2' ' B' ' 105' ' ' ARG . 76.1 p . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.185 0.517 . . . . 0.97999999999999998 110.955 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ILE . . . . . 0.611 ' O ' ' HD2' ' B' ' 105' ' ' ARG . 47.1 mt -71.46 136.28 26.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 105.676 -1.972 . . . . 0.94999999999999996 105.676 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.1 144.7 36.27 Favored 'General case' 0 C--O 1.209 -1.078 0 CA-C-N 115.319 -0.855 . . . . 0.83999999999999997 110.52 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 40.8 mt -126.53 130.91 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 108.436 -0.95 . . . . 0.68000000000000005 108.436 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 92.3 t -125.08 128.81 73.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 105.711 -1.959 . . . . 0.70999999999999996 105.711 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.559 HG23 ' HB2' ' B' ' 14' ' ' ALA . 38.2 mt -108.66 132.72 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.27 -0.641 . . . . 0.52000000000000002 109.27 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.67 133.94 6.69 Favored Glycine 0 N--CA 1.472 1.084 0 C-N-CA 120.086 -1.054 . . . . 0.55000000000000004 110.846 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.496 HG22 ' N ' ' B' ' 14' ' ' ALA . 14.9 t -146.0 162.07 38.68 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.209 -1.404 . . . . 1.1299999999999999 107.209 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -68.62 144.03 54.63 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 102.948 -2.982 . . . . 2.25 102.948 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.83 -141.96 26.01 Favored Glycine 0 C--N 1.306 -1.108 0 C-N-CA 117.237 -2.411 . . . . 0.59999999999999998 114.109 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -123.5 26.16 7.94 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 113.945 1.091 . . . . 0.93999999999999995 113.945 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.16 -26.77 42.71 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.898 1.444 . . . . 0.40000000000000002 114.898 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.559 ' HB2' HG23 ' B' ' 7' ' ' ILE . . . -55.36 -46.18 76.48 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.154 0.888 . . . . 0.41999999999999998 112.379 -176.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -59.98 -40.16 88.15 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.485 -0.486 . . . . 0.56000000000000005 110.928 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.31 -34.27 70.45 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.34 0.867 . . . . 0.48999999999999999 113.34 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 85.4 mt -65.34 -38.79 91.2 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 106.706 -1.59 . . . . 0.31 106.706 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' LEU . . . . . 0.5 HD11 HG11 ' B' ' 31' ' ' VAL . 18.9 tp -66.27 -43.81 85.41 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.537 -0.912 . . . . 0.53000000000000003 108.537 178.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -61.02 -39.01 88.13 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.923 0.392 . . . . 0.58999999999999997 111.092 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 16.7 m -64.49 -46.9 81.01 Favored 'General case' 0 C--O 1.248 1.026 0 N-CA-C 108.268 -1.012 . . . . 0.42999999999999999 108.268 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.83 -44.21 90.87 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 119.875 -0.73 . . . . 0.52000000000000002 110.841 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 1.301 ' OE2' ' HG2' ' B' ' 27' ' ' GLU . 15.0 tt0 -68.52 -22.63 64.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.345 -0.388 . . . . 2.3900000000000001 110.478 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -32.27 68.69 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 105.448 -2.056 . . . . 2.1499999999999999 105.448 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 81.1 mt -84.15 -39.07 19.87 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.522 0.934 . . . . 1.2 113.522 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.449 HD13 HG12 ' B' ' 99' ' ' VAL . 95.4 mt -109.12 -11.82 14.89 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 118.636 2.828 . . . . 1.25 118.636 -175.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' B' ' 22' ' ' GLU . . . 98.37 165.67 31.0 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 105.247 -3.141 . . . . 0.78000000000000003 105.247 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . 1.301 ' HG2' ' OE2' ' B' ' 22' ' ' GLU . 40.4 mt-10 -59.88 138.84 57.71 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 122.609 1.195 . . . . 0.81999999999999995 112.217 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -105.62 147.06 28.87 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 112.913 -1.949 . . . . 0.72999999999999998 112.918 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -106.22 158.44 16.84 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.952 -1.476 . . . . 0.94999999999999996 107.47 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 29.9 t30 57.43 42.07 25.24 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.64 -1.164 . . . . 0.83999999999999997 113.9 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.5 HG11 HD11 ' B' ' 18' ' ' LEU . 94.1 t -131.02 135.03 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.115 -1.069 . . . . 0.68999999999999995 108.115 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.85 168.19 19.07 Favored Glycine 0 N--CA 1.477 1.38 0 N-CA-C 109.404 -1.478 . . . . 0.64000000000000001 109.404 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -156.12 158.61 37.99 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.783 -0.821 . . . . 0.60999999999999999 108.783 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 pt -137.67 160.0 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 O-C-N 124.002 0.814 . . . . 0.69999999999999996 109.403 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -114.98 163.41 15.62 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 108.493 -0.929 . . . . 0.68000000000000005 108.493 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' B' ' 36' ' ' PHE . 1.6 t80 -134.91 116.91 15.27 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.605 -1.628 . . . . 0.88 106.605 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.457 HG12 ' HD2' ' B' ' 38' ' ' PRO . 95.9 t -107.83 145.55 31.6 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 113.876 -1.511 . . . . 0.87 110.601 -176.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.457 ' HD2' HG12 ' B' ' 37' ' ' VAL . 67.5 Cg_exo -56.6 134.98 67.83 Favored 'Trans proline' 0 C--N 1.346 0.446 0 N-CA-C 108.302 -1.461 . . . . 0.94999999999999996 108.302 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.41 -25.3 15.83 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.415 -1.474 . . . . 1.0600000000000001 109.415 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -84.61 158.31 20.92 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.583 0.706 . . . . 1.0 109.592 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -125.86 179.44 5.19 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.952 -1.129 . . . . 2.9100000000000001 107.952 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.92 -34.57 73.4 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.538 0.57 . . . . 1.03 112.538 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.43 -36.3 83.51 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.261 0.553 . . . . 3.02 111.66 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 88.4 m -63.6 -47.58 80.84 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 106.033 -1.84 . . . . 1.02 106.033 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.455 HD12 ' HB3' ' B' ' 72' ' ' SER . 35.0 mt -63.62 -36.48 83.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.213 -0.595 . . . . 0.92000000000000004 112.344 -177.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.86 -42.75 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 107.948 -1.131 . . . . 1.0700000000000001 107.948 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -62.89 -42.56 99.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 120.046 -0.662 . . . . 1.0900000000000001 110.304 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -62.35 -43.09 99.65 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 119.348 -0.941 . . . . 0.88 110.906 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -62.49 -45.43 93.05 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 108.719 -0.845 . . . . 0.82999999999999996 108.719 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -60.73 -39.82 90.06 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.383 0.512 . . . . 1.03 112.383 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.05 -34.82 79.33 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.34 -0.544 . . . . 0.93999999999999995 109.802 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -70.99 -43.79 67.28 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 119.589 -0.844 . . . . 0.81999999999999995 109.437 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' B' ' 53' ' ' LEU . 88.3 mt -59.97 -37.7 80.4 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.52 -0.309 . . . . 0.91000000000000003 111.582 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.72 -25.77 29.6 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.257 0.466 . . . . 1.02 112.257 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -96.27 -4.63 41.92 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 112.397 0.517 . . . . 0.93999999999999995 112.397 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 74.6 mt -105.6 158.5 16.65 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.748 0.648 . . . . 0.93999999999999995 112.748 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -90.36 107.42 19.14 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 102.382 -3.192 . . . . 1.02 102.382 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 73.4 p -106.53 15.07 26.32 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 124.267 0.979 . . . . 1.01 110.826 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 72.1 p -63.6 -33.94 76.72 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 115.249 1.574 . . . . 1.1399999999999999 115.249 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -92.82 -8.87 42.33 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.394 0.434 . . . . 1.1699999999999999 111.41 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.71 172.04 12.98 Favored Glycine 0 C--N 1.314 -0.683 0 C-N-CA 119.341 -1.409 . . . . 0.97999999999999998 112.882 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 58.6 t -138.95 130.82 36.42 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 109.17 -0.678 . . . . 0.90000000000000002 109.17 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.55 ' HG ' HD23 ' B' ' 65' ' ' LEU . 29.6 tp -116.48 115.0 24.98 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 125.325 1.64 . . . . 0.77000000000000002 107.508 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -92.57 122.34 34.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 105.637 -1.986 . . . . 0.83999999999999997 105.637 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.55 HD23 ' HG ' ' B' ' 63' ' ' LEU . 83.0 mt -109.66 114.98 29.04 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 104.636 -2.357 . . . . 0.59999999999999998 104.636 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.07 163.86 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 121.67 0.748 . . . . 0.64000000000000001 112.752 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' B' ' 67' ' ' ASP . 12.5 p-10 -65.62 -54.55 26.22 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 117.193 2.294 . . . . 0.53000000000000003 117.193 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 74.5 p -141.57 151.48 43.23 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.57 1.176 . . . . 1.1699999999999999 112.7 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -65.98 134.4 52.86 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 113.77 -1.559 . . . . 1.02 107.959 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.79 -7.04 75.89 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 120.137 2.815 . . . . 0.90000000000000002 120.137 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.4 174.84 54.99 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 119.607 1.704 . . . . 0.81000000000000005 109.356 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.468 ' HB2' ' HD3' ' B' ' 73' ' ' PRO . 20.4 m -57.58 -47.23 99.33 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 122.131 -0.629 . . . . 1.9099999999999999 111.755 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' B' ' 72' ' ' SER . 85.7 Cg_exo -53.74 -41.81 71.26 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 N-CA-C 110.327 -0.682 . . . . 0.72999999999999998 110.327 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -67.4 -48.66 66.72 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.531 0.52 . . . . 0.95999999999999996 109.605 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -60.0 -42.48 94.35 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.689 0.996 . . . . 2.54 113.689 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.91 84.97 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.322 -0.951 . . . . 0.93999999999999995 111.401 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.18 90.04 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.553 -0.906 . . . . 0.89000000000000001 108.553 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 3.4 m -59.28 -38.84 81.13 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.121 0.415 . . . . 2.02 112.121 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.475 HH11 ' HD3' ' B' ' 79' ' ' ARG . 3.6 mtt180 -68.61 -29.33 67.82 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.617 -0.433 . . . . 3.9399999999999999 112.106 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 72.8 mt -77.24 -42.98 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 111.943 0.349 . . . . 1.04 111.943 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' B' ' 87' ' ' TYR . 2.5 m -78.93 -17.6 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 115.438 1.644 . . . . 1.0700000000000001 115.438 -175.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . 0.441 HG21 ' O ' ' B' ' 79' ' ' ARG . 10.5 m -29.11 -55.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 121.398 3.851 . . . . 1.6899999999999999 121.398 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.04 38.97 4.04 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 116.708 -1.997 . . . . 1.3200000000000001 109.057 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.48 133.71 54.4 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.62 -1.173 . . . . 1.1699999999999999 109.514 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -78.68 141.59 37.82 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.666 -1.605 . . . . 1.29 106.666 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 61.0 m170 62.45 35.23 14.89 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 114.435 1.272 . . . . 1.1899999999999999 114.435 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' TYR . . . . . 0.478 ' HB3' ' HB ' ' B' ' 81' ' ' VAL . 6.2 m-85 -128.46 129.95 46.85 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.257 -2.127 . . . . 1.02 105.257 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . 0.403 ' HG2' HG13 ' B' ' 115' ' ' VAL . 6.8 tp10 -145.61 156.18 43.51 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.181 -0.608 . . . . 0.93000000000000005 110.293 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 19.1 t -122.6 128.7 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 N-CA-C 105.638 -1.986 . . . . 0.85999999999999999 105.638 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 34.2 mt -124.7 120.75 59.65 Favored 'Isoleucine or valine' 0 C--O 1.251 1.167 0 N-CA-C 107.536 -1.283 . . . . 0.73999999999999999 107.536 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.35 164.08 17.28 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 114.616 -1.175 . . . . 0.68000000000000005 111.087 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.37 24.31 57.02 Favored Glycine 0 CA--C 1.502 -0.772 0 CA-C-N 115.608 -0.724 . . . . 0.53000000000000003 114.569 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 11.9 p -48.67 132.98 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 112.903 0.705 . . . . 0.44 112.903 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' ASN . . . . . 0.577 ' HB3' ' HB3' ' A' ' 94' ' ' ASN . 52.6 p30 -142.22 170.14 16.28 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.503 -1.295 . . . . 0.44 107.503 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 46.8 mm -61.65 -42.56 84.38 Favored Pre-proline 0 C--O 1.243 0.72 0 N-CA-C 113.833 1.049 . . . . 1.0800000000000001 113.833 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' B' ' 94' ' ' ASN . 24.7 Cg_exo -57.12 -43.79 50.0 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 CA-C-N 119.726 0.938 . . . . 0.51000000000000001 110.091 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' MET . . . . . 0.454 ' CE ' HG13 ' A' ' 126' ' ' VAL . 40.4 ttm -61.42 -48.84 79.34 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 120.289 -0.564 . . . . 0.56999999999999995 109.596 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.408 ' HG ' HD12 ' B' ' 102' ' ' LEU . 14.6 tp -61.21 -47.58 85.47 Favored 'General case' 0 C--O 1.205 -1.286 0 C-N-CA 120.371 -0.532 . . . . 0.51000000000000001 112.095 -176.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . 0.449 HG12 HD13 ' B' ' 25' ' ' LEU . 93.7 t -62.36 -49.24 84.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 112.385 0.513 . . . . 1.1899999999999999 112.385 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . 0.598 ' HA ' ' OE1' ' B' ' 100' ' ' GLU . 0.1 OUTLIER -63.91 -40.91 97.57 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.216 -0.594 . . . . 2.0600000000000001 111.159 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' THR . . . . . . . . . . . . . 54.0 m -66.06 -45.65 80.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.87 -0.605 . . . . 0.69999999999999996 110.852 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.408 HD12 ' HG ' ' B' ' 98' ' ' LEU . 97.5 mt -65.15 -37.5 87.61 Favored 'General case' 0 CA--C 1.551 0.991 0 O-C-N 123.563 0.539 . . . . 0.73999999999999999 110.014 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' MET . . . . . 0.435 ' HB2' ' HE2' ' B' ' 103' ' ' MET . 2.3 mtm -66.34 -45.91 78.63 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 121.369 -0.832 . . . . 1.6100000000000001 111.766 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.81 -33.64 75.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.904 0.705 . . . . 1.3200000000000001 112.904 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.611 ' HD2' ' O ' ' B' ' 3' ' ' ILE . 13.0 ttp180 -53.04 -32.86 49.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.86 -0.609 . . . . 0.91000000000000003 112.632 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.21 -19.77 61.01 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 113.728 1.011 . . . . 2.3500000000000001 113.728 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -90.54 18.19 6.56 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.805 0.812 . . . . 2.29 109.271 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 13.9 t70 46.86 59.12 16.62 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 116.232 1.938 . . . . 1.1499999999999999 116.232 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.79 168.86 23.74 Favored 'Trans proline' 0 C--O 1.207 -1.06 0 C-N-CA 120.981 1.121 . . . . 1.0700000000000001 110.427 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' SER . . . . . 0.483 ' HG ' ' CG ' ' B' ' 113' ' ' GLU . 54.5 p -77.87 163.17 26.29 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 106.351 -1.722 . . . . 1.1599999999999999 106.351 175.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -56.78 -51.18 69.94 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 119.059 -0.496 . . . . 1.0700000000000001 111.855 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -59.31 -36.28 75.34 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.817 0.735 . . . . 1.1699999999999999 112.5 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . 0.483 ' CG ' ' HG ' ' B' ' 110' ' ' SER . 88.0 mt-10 -64.71 -45.84 84.83 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.331 -0.618 . . . . 1.1699999999999999 109.331 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . . . . . . . . . 15.6 tp -65.43 -44.91 85.87 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 120.711 -0.396 . . . . 0.93999999999999995 110.763 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.403 HG13 ' HG2' ' B' ' 88' ' ' GLU . 58.8 t -57.79 -47.81 85.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.382 -0.527 . . . . 0.92000000000000004 109.994 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.26 97.84 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 111.958 0.355 . . . . 0.98999999999999999 111.958 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.41 HD11 HG21 ' B' ' 121' ' ' THR . 55.0 tp -63.74 -42.28 97.9 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 119.444 -0.312 . . . . 1.3600000000000001 110.363 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.7 -44.49 96.5 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.876 -0.729 . . . . 0.76000000000000001 111.875 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.43 -46.27 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.313 -0.625 . . . . 0.83999999999999997 109.313 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -63.58 -45.54 89.96 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.137 0.792 . . . . 0.94999999999999996 113.137 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' THR . . . . . 0.41 HG21 HD11 ' B' ' 117' ' ' LEU . 57.5 p -71.75 -31.53 66.76 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 120.38 -0.528 . . . . 1.28 111.774 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.12 -45.78 94.7 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 108.86 -1.696 . . . . 0.62 108.86 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 9.2 mtp-105 -72.65 -41.72 65.16 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 112.213 0.449 . . . . 0.87 112.213 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -70.59 -19.82 62.82 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.468 -0.893 . . . . 2.5 111.576 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.52 -16.31 77.55 Favored Glycine 0 CA--C 1.534 1.223 0 O-C-N 124.105 0.878 . . . . 0.58999999999999997 112.829 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 94.3 t -89.66 111.63 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 106.453 -1.684 . . . . 0.62 106.453 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -154.69 138.02 15.79 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.861 -0.792 . . . . 3.1699999999999999 108.861 -173.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.31 147.53 23.39 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 122.036 0.922 . . . . 1.24 109.482 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' B' ' 130' ' ' LYS . 41.9 tp -67.9 -58.12 5.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.114 -0.948 . . . . 1.3100000000000001 110.653 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' B' ' 129' ' ' LEU . 76.5 mttt . . . . . 1 C--O 1.433 10.713 1 CA-C-O 145.661 12.172 . . . . 3.1400000000000001 110.616 177.829 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' D' D ' 159' ' ' ASN . . . . . 0.763 ' ND2' ' HZ2' ' D' ' 259' ' ' LYS . 1.8 t-20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 108.988 -0.745 . . . . 1.3999999999999999 108.988 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 160' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -85.89 25.54 1.1 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.449 -0.945 . . . . 1.6499999999999999 108.449 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 161' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -118.62 -141.9 0.36 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.619 -0.882 . . . . 1.6100000000000001 108.619 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 162' ' ' MET . . . . . 0.551 ' SD ' ' CG2' ' D' ' 240' ' ' VAL . 0.3 OUTLIER -61.75 156.13 21.1 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.895 -1.128 . . . . 1.25 110.492 -178.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 163' ' ' VAL . . . . . . . . . . . . . 93.2 t -113.04 117.76 56.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 109.142 -0.688 . . . . 1.28 109.142 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 164' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.66 103.33 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.56 -0.904 . . . . 0.96999999999999997 108.56 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.65 -35.2 80.1 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.121 -1.592 . . . . 0.93999999999999995 109.121 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 tp -172.13 147.94 2.13 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.86 -1.136 . . . . 0.77000000000000002 111.27 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 167' ' ' ALA . . . . . . . . . . . . . . . -117.68 104.14 10.71 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.167 -0.679 . . . . 0.58999999999999997 109.167 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 168' ' ' ARG . . . . . 0.481 ' NH1' ' CG1' ' D' ' 178' ' ' VAL . 44.4 ttp180 -106.2 126.01 51.69 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.923 0.868 . . . . 0.59999999999999998 110.983 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 169' ' ' ILE . . . . . . . . . . . . . 82.1 mt -95.55 129.27 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 109.183 -0.673 . . . . 0.39000000000000001 109.183 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 170' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -165.88 117.07 1.05 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.417 -0.802 . . . . 0.42999999999999999 110.349 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 171' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -62.89 -10.07 12.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.564 -0.71 . . . . 0.5 109.794 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 172' ' ' ARG . . . . . 0.68 ' NH2' ' CE1' ' D' ' 175' ' ' HIS . 88.0 mtm180 -101.7 -3.9 27.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.905 -1.122 . . . . 0.76000000000000001 110.418 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 173' ' ' LEU . . . . . 0.592 ' N ' ' CD1' ' D' ' 173' ' ' LEU . 6.8 mp 56.06 -99.77 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 120.101 -0.64 . . . . 0.39000000000000001 109.372 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 174' ' ' ILE . . . . . 0.446 HD12 HG22 ' D' ' 174' ' ' ILE . 96.5 mt -105.66 113.58 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.017 -1.052 . . . . 0.62 109.32 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 175' ' ' HIS . . . . . 0.68 ' CE1' ' NH2' ' D' ' 172' ' ' ARG . 10.4 p80 -142.01 120.7 12.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.251 -0.905 . . . . 1.0 108.648 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 176' ' ' GLY . . . . . . . . . . . . . . . 79.95 -141.18 23.12 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 110.027 -1.229 . . . . 0.87 110.027 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 177' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' D' ' 178' ' ' VAL . 4.7 pt20 -113.04 4.76 16.84 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.427 -0.953 . . . . 1.25 108.427 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 178' ' ' VAL . . . . . 0.481 ' CG1' ' NH1' ' D' ' 168' ' ' ARG . 38.1 t -48.22 -42.61 11.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 117.499 -1.68 . . . . 0.82999999999999996 108.597 171.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 179' ' ' ALA . . . . . 0.501 ' O ' ' OG1' ' D' ' 183' ' ' THR . . . -73.24 -36.34 66.42 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.002 -1.061 . . . . 0.81000000000000005 110.142 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 180' ' ' THR . . . . . . . . . . . . . 21.7 m -66.28 -54.73 21.43 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.77 -0.772 . . . . 1.1000000000000001 109.671 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 181' ' ' ARG . . . . . 0.423 ' NH1' ' CG2' ' D' ' 308' ' ' THR . 73.6 ttt180 -64.59 -43.73 92.9 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.624 -0.672 . . . . 1.3400000000000001 110.583 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 182' ' ' TRP . . . . . 0.471 ' CH2' ' ND2' ' D' ' 264' ' ' ASN . 19.6 m95 -65.85 -32.04 73.34 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.131 -0.981 . . . . 0.90000000000000002 109.589 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 183' ' ' THR . . . . . 0.501 ' OG1' ' O ' ' D' ' 179' ' ' ALA . 69.3 m -65.4 -46.99 77.86 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.926 -1.108 . . . . 1.04 110.166 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 184' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -69.93 -42.77 72.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.148 -0.97 . . . . 1.45 110.656 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 185' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -68.41 -39.53 81.59 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.806 -1.184 . . . . 1.29 109.615 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 186' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' D' ' 182' ' ' TRP . 72.9 p -81.32 -1.39 45.09 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.2 -0.937 . . . . 1.05 109.682 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 187' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 52.18 48.4 22.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.087 -1.008 . . . . 1.4199999999999999 108.637 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 188' ' ' VAL . . . . . 0.443 HG11 ' H ' ' D' ' 190' ' ' ARG . 47.8 t -104.97 133.54 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.146 -0.971 . . . . 1.05 110.027 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 189' ' ' SER . . . . . . . . . . . . . 27.4 p -109.78 -6.44 15.27 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.804 -0.813 . . . . 1.22 108.804 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 190' ' ' ARG . . . . . 0.443 ' H ' HG11 ' D' ' 188' ' ' VAL . 29.3 mtt-85 -135.84 142.92 44.87 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.484 0.659 . . . . 1.3300000000000001 110.41 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 191' ' ' ILE . . . . . . . . . . . . . 87.5 mt -133.3 127.46 54.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.243 -1.021 . . . . 0.81999999999999995 108.243 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 192' ' ' ILE . . . . . . . . . . . . . 97.1 mt -115.48 128.86 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.205 -0.934 . . . . 0.91000000000000003 109.734 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 193' ' ' VAL . . . . . . . . . . . . . 53.8 t -99.86 129.1 51.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.711 -0.848 . . . . 0.58999999999999997 108.711 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 194' ' ' VAL . . . . . . . . . . . . . 42.5 t -112.75 103.75 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.487 -0.758 . . . . 0.66000000000000003 109.334 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 195' ' ' SER . . . . . . . . . . . . . 37.5 t -167.36 125.69 1.29 Allowed 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.301 -0.96 . . . . 0.60999999999999999 109.276 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 196' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.23 -34.76 66.07 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.512 -0.742 . . . . 0.87 109.791 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 197' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -65.66 -45.37 83.21 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.021 -1.049 . . . . 0.73999999999999999 109.991 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 198' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.26 -43.0 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.16 -0.962 . . . . 0.62 109.062 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.63 -26.53 56.14 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.681 -0.807 . . . . 0.80000000000000004 109.151 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 200' ' ' ALA . . . . . . . . . . . . . . . -84.9 -5.34 59.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.986 -1.071 . . . . 0.88 109.905 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 201' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -102.87 95.38 6.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.901 -1.124 . . . . 0.75 109.546 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 202' ' ' THR . . . . . . . . . . . . . 61.2 p -66.11 -33.17 75.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 1.9399999999999999 110.583 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 203' ' ' VAL . . . . . . . . . . . . . 65.6 t -66.54 -47.35 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.769 -1.207 . . . . 1.3300000000000001 109.472 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 204' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -63.87 -42.16 97.59 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.348 -0.941 . . . . 0.64000000000000001 109.453 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 205' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -58.11 -42.36 85.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.092 -1.005 . . . . 0.93000000000000005 109.338 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 206' ' ' THR . . . . . . . . . . . . . 99.2 m -60.63 -48.82 80.08 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.098 -1.041 . . . . 1.3500000000000001 109.528 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 207' ' ' LEU . . . . . 0.431 ' O ' HG21 ' D' ' 211' ' ' VAL . 92.8 mt -62.7 -44.25 96.72 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.92 -1.113 . . . . 1.3300000000000001 110.81 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 208' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.6 -41.5 99.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.693 -1.254 . . . . 0.67000000000000004 110.145 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 209' ' ' THR . . . . . . . . . . . . . 73.6 p -67.72 -31.86 72.09 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.429 -0.794 . . . . 1.3 110.31 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 210' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -80.42 -17.61 51.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.787 -1.196 . . . . 3.0800000000000001 110.808 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 211' ' ' VAL . . . . . 0.431 HG21 ' O ' ' D' ' 207' ' ' LEU . 17.6 m -107.61 17.52 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.09 -1.006 . . . . 1.3400000000000001 108.77 178.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.04 123.42 82.03 Favored Pre-proline 0 N--CA 1.482 1.134 0 N-CA-C 107.868 -1.16 . . . . 0.94999999999999996 107.868 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 213' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -44.29 144.51 2.9 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 122.11 1.873 . . . . 1.03 112.688 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 214' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.46 134.85 66.95 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.161 1.907 . . . . 1.28 112.146 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . 79.82 -8.58 49.19 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.024 -1.231 . . . . 1.29 110.024 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 216' ' ' VAL . . . . . . . . . . . . . 56.0 t -114.66 136.82 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -1.105 . . . . 1.1000000000000001 108.94 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 217' ' ' THR . . . . . . . . . . . . . 6.8 p -104.84 135.74 45.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.431 -0.793 . . . . 1.1499999999999999 109.921 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 218' ' ' ALA . . . . . . . . . . . . . . . -110.11 131.28 55.2 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.175 -1.046 . . . . 0.85999999999999999 108.175 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 219' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -120.95 153.51 37.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.457 -0.777 . . . . 1.0700000000000001 109.734 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 65.9 t -126.44 117.91 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.649 0.738 . . . . 0.80000000000000004 109.09 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 221' ' ' VAL . . . . . . . . . . . . . 31.3 m -140.92 165.11 20.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.516 -0.74 . . . . 0.93000000000000005 109.512 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 222' ' ' ASP . . . . . 0.712 ' OD1' ' N ' ' D' ' 225' ' ' LYS . 6.6 p30 -94.24 167.02 11.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.493 -0.754 . . . . 1.0 109.305 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 69.0 t -57.38 -44.73 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.049 -1.032 . . . . 0.92000000000000004 110.429 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 224' ' ' ALA . . . . . 0.473 ' O ' HG23 ' D' ' 227' ' ' ILE . . . -62.79 -44.81 95.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.005 -1.06 . . . . 1.1699999999999999 109.353 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 225' ' ' LYS . . . . . 0.712 ' N ' ' OD1' ' D' ' 222' ' ' ASP . 45.7 tttm -68.26 -35.06 77.32 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.863 -1.148 . . . . 1.2 109.58 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 226' ' ' MET . . . . . . . . . . . . . 10.3 tpt -62.22 -40.36 95.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.015 -1.053 . . . . 0.98999999999999999 111.124 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 227' ' ' ILE . . . . . 0.53 HG23 ' N ' ' D' ' 228' ' ' ARG . 17.3 tt -60.85 -34.59 59.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.683 -0.858 . . . . 1.21 108.683 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 228' ' ' ARG . . . . . 0.53 ' N ' HG23 ' D' ' 227' ' ' ILE . 0.4 OUTLIER -74.52 -38.9 62.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.802 -0.561 . . . . 1.5600000000000001 110.913 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.22 -41.66 92.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.8 -1.185 . . . . 1.22 107.8 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 230' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' D' ' 230' ' ' TYR . 36.9 t80 -67.24 -32.07 72.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.08 -1.013 . . . . 1.25 109.788 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 231' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.77 6.8 2.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.055 -1.028 . . . . 1.48 110.113 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 232' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -110.35 117.69 50.77 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.134 -0.979 . . . . 1.5600000000000001 109.366 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 233' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -64.97 0.5 2.51 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.608 1.539 . . . . 1.7 111.932 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 234' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -59.99 -24.56 64.55 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.056 -1.028 . . . . 1.6200000000000001 108.8 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 235' ' ' TYR . . . . . 0.495 ' O ' ' HB2' ' D' ' 238' ' ' GLU . 81.1 m-85 -105.58 15.75 26.51 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.57 -0.852 . . . . 1.3999999999999999 108.988 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 236' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' D' ' 238' ' ' GLU . . . -54.74 135.79 46.84 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.055 -1.653 . . . . 1.5600000000000001 109.655 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.61 -33.42 1.86 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.339 -1.504 . . . . 1.46 109.339 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 238' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' D' ' 235' ' ' TYR . 4.0 mm-40 -54.27 138.97 37.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.823 -1.398 . . . . 1.3700000000000001 109.367 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 239' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -99.11 116.29 30.98 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.443 -0.947 . . . . 1.3999999999999999 108.443 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 240' ' ' VAL . . . . . 0.551 ' CG2' ' SD ' ' D' ' 162' ' ' MET . 26.3 t -121.83 148.68 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.829 0.823 . . . . 1.03 110.492 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 241' ' ' MET . . . . . . . . . . . . . 13.7 ttm -102.7 134.81 45.47 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.008 -1.108 . . . . 0.77000000000000002 108.008 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 242' ' ' LEU . . . . . . . . . . . . . 61.0 mt -102.0 127.24 48.96 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.949 0.88 . . . . 0.72999999999999998 109.878 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 243' ' ' LEU . . . . . . . . . . . . . 97.5 mt -109.27 126.05 52.93 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.877 0.846 . . . . 0.45000000000000001 109.155 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 244' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -127.02 161.99 27.07 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.78 0.8 . . . . 0.56000000000000005 109.4 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 245' ' ' THR . . . . . . . . . . . . . 69.4 p -109.44 -19.55 13.21 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.748 0.785 . . . . 0.39000000000000001 109.012 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 246' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' D' ' 246' ' ' ASN . 17.2 p30 -151.01 141.73 14.84 Favored Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 119.935 -0.706 . . . . 0.56000000000000005 109.912 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 247' ' ' PRO . . . . . 0.43 ' HG3' ' CE2' ' D' ' 291' ' ' PHE . 7.4 Cg_endo -60.71 -14.53 32.14 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.627 2.218 . . . . 0.57999999999999996 112.185 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 248' ' ' THR . . . . . . . . . . . . . 96.1 m -65.14 -42.66 93.6 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.435 -0.95 . . . . 0.81000000000000005 108.435 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 249' ' ' ASP . . . . . 0.455 ' O ' HD11 ' D' ' 253' ' ' LEU . 97.8 m-20 -67.33 -23.37 65.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.566 -0.709 . . . . 0.66000000000000003 109.85 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 250' ' ' VAL . . . . . . . . . . . . . 98.4 t -73.97 -43.69 51.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.589 -1.319 . . . . 0.68000000000000005 109.697 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 251' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -62.37 -35.0 77.79 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.229 -0.988 . . . . 0.93000000000000005 108.491 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 252' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -62.34 -44.16 97.13 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.335 -0.853 . . . . 1.04 110.193 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 253' ' ' LEU . . . . . 0.455 HD11 ' O ' ' D' ' 249' ' ' ASP . 1.2 mp -64.08 -40.32 96.0 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.881 -1.528 . . . . 0.93000000000000005 108.867 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 254' ' ' VAL . . . . . . . . . . . . . 70.8 t -60.78 -44.59 97.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.715 -1.24 . . . . 1.01 108.905 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 255' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.37 -30.86 69.84 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.899 -1.126 . . . . 1.1699999999999999 109.906 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 256' ' ' GLY . . . . . . . . . . . . . . . -74.37 2.91 43.41 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.544 -1.422 . . . . 1.2 109.544 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.46 15.81 45.55 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.599 -1.401 . . . . 1.21 109.599 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 258' ' ' VAL . . . . . . . . . . . . . 95.6 t -77.91 139.7 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 106.886 -1.524 . . . . 1.03 106.886 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 259' ' ' LYS . . . . . 0.763 ' HZ2' ' ND2' ' D' ' 159' ' ' ASN . 17.7 tttt -98.97 123.74 43.46 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.972 -1.08 . . . . 1.24 110.912 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 260' ' ' ILE . . . . . . . . . . . . . 98.1 mt -130.09 125.42 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.537 -0.727 . . . . 0.85999999999999999 109.15 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 64.8 p -89.26 -31.54 17.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.699 -1.251 . . . . 0.97999999999999998 110.202 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 262' ' ' SER . . . . . . . . . . . . . 15.7 m -159.06 153.43 24.02 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.168 -0.957 . . . . 0.81000000000000005 110.071 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 263' ' ' VAL . . . . . . . . . . . . . 51.2 t -122.65 134.51 65.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.615 -0.883 . . . . 0.60999999999999999 108.615 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 264' ' ' ASN . . . . . 0.471 ' ND2' ' CH2' ' D' ' 182' ' ' TRP . 33.5 t30 -108.51 128.19 54.59 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.543 0.687 . . . . 0.64000000000000001 110.609 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 265' ' ' VAL . . . . . 0.423 HG22 ' SD ' ' D' ' 314' ' ' MET . 3.2 t -90.76 108.39 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.475 0.655 . . . . 0.58999999999999997 109.69 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 266' ' ' GLY . . . . . . . . . . . . . . . -80.78 -53.82 3.87 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.184 -1.166 . . . . 0.62 110.184 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 267' ' ' GLY . . . . . . . . . . . . . . . -172.61 152.99 17.82 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 118.715 -1.707 . . . . 0.59999999999999998 111.462 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 268' ' ' MET . . . . . . . . . . . . . 97.0 mtp -143.12 118.09 10.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.533 -0.981 . . . . 0.70999999999999996 110.392 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.21 128.2 21.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.421 -0.799 . . . . 0.77000000000000002 109.489 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 270' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' D' ' 271' ' ' ARG . 16.3 t80 -69.79 161.89 28.95 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.117 -0.99 . . . . 1.26 109.672 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 271' ' ' ARG . . . . . 0.54 ' N ' ' CD1' ' D' ' 270' ' ' PHE . 2.3 mmt180 -160.72 158.56 28.88 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.043 -1.036 . . . . 1.1899999999999999 109.69 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 272' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -66.46 138.22 57.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.93 -1.107 . . . . 1.3899999999999999 110.366 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 273' ' ' GLY . . . . . . . . . . . . . . . 95.54 -12.29 67.82 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.721 -1.752 . . . . 1.3300000000000001 108.721 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 274' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -101.72 163.46 12.25 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.434 -1.039 . . . . 1.1899999999999999 109.489 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 275' ' ' THR . . . . . . . . . . . . . 20.8 m -110.01 135.77 50.33 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.686 -0.857 . . . . 1.25 108.686 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 276' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -81.97 119.37 23.88 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.225 -0.922 . . . . 1.25 110.146 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 277' ' ' VAL . . . . . 0.454 HG22 ' N ' ' D' ' 278' ' ' ASN . 27.4 m -99.18 -28.41 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.433 -0.792 . . . . 1.0700000000000001 109.622 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 278' ' ' ASN . . . . . 0.471 HD21 HG13 ' D' ' 303' ' ' VAL . 10.4 t-20 -135.85 -177.17 4.57 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.862 0.839 . . . . 1.05 109.659 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 279' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -57.03 -29.69 63.59 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.663 -0.648 . . . . 1.28 110.836 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 280' ' ' ALA . . . . . . . . . . . . . . . -148.17 27.07 0.96 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.773 -1.205 . . . . 0.94999999999999996 109.548 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 281' ' ' VAL . . . . . . . . . . . . . 60.5 t -119.05 121.79 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.868 -0.733 . . . . 0.89000000000000001 109.755 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 282' ' ' SER . . . . . . . . . . . . . 29.1 m -118.52 147.62 43.47 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.436 0.636 . . . . 0.92000000000000004 110.022 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 283' ' ' VAL . . . . . 0.43 HG22 HG11 ' D' ' 277' ' ' VAL . 16.4 m -135.18 142.77 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 122.389 1.09 . . . . 0.95999999999999996 110.52 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 284' ' ' ASP . . . . . 0.6 ' OD1' ' N ' ' D' ' 287' ' ' ASP . 44.1 p-10 -110.73 171.62 7.36 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.971 -1.492 . . . . 1.0 106.971 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 285' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -56.18 -24.03 38.96 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.793 -1.192 . . . . 1.3300000000000001 109.669 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 286' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -79.73 -43.38 22.73 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.948 -1.095 . . . . 0.97999999999999998 110.054 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 287' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' D' ' 284' ' ' ASP . 93.1 m-20 -64.2 -42.24 96.72 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.145 -0.972 . . . . 0.82999999999999996 109.136 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 288' ' ' ILE . . . . . . . . . . . . . 88.9 mt -62.41 -45.88 97.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.247 -0.908 . . . . 1.03 109.462 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 289' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -57.3 -39.43 75.75 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.167 -0.958 . . . . 1.1499999999999999 110.435 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.58 -40.98 84.83 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.815 -1.178 . . . . 0.80000000000000004 109.881 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 291' ' ' PHE . . . . . 0.444 ' CE2' ' HE3' ' D' ' 314' ' ' MET . 40.3 m-85 -63.83 -39.22 93.71 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.375 -0.828 . . . . 0.75 109.666 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 292' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -63.95 -39.39 94.04 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.29 -0.964 . . . . 1.1299999999999999 110.197 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 293' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -65.97 -41.49 91.13 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.836 -1.165 . . . . 1.1200000000000001 109.486 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 294' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.21 -43.17 99.44 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.984 -1.072 . . . . 0.80000000000000004 108.832 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 295' ' ' ASN . . . . . 0.535 HD21 ' HG3' ' D' ' 315' ' ' MET . 40.4 t-20 -63.96 -40.13 95.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.117 -0.989 . . . . 0.93000000000000005 109.881 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.62 -21.35 65.6 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.837 -1.164 . . . . 1.03 109.256 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 297' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -90.22 9.02 30.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.847 -1.158 . . . . 1.1100000000000001 109.848 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.28 11.34 82.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.884 -1.286 . . . . 0.96999999999999997 109.884 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 299' ' ' ILE . . . . . 0.426 HD12 HG23 ' D' ' 299' ' ' ILE . 97.7 mt -84.62 134.66 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.938 -1.33 . . . . 0.83999999999999997 109.107 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 300' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -82.1 141.78 32.85 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.473 -0.891 . . . . 0.94999999999999996 110.664 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 301' ' ' LEU . . . . . . . . . . . . . 67.1 mt -123.07 111.27 16.36 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.328 -0.619 . . . . 0.75 109.328 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 302' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -115.66 140.09 49.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.395 -0.815 . . . . 0.87 110.162 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 303' ' ' VAL . . . . . 0.615 ' CG2' ' SD ' ' D' ' 314' ' ' MET . 52.6 t -112.02 124.92 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.751 -0.833 . . . . 0.83999999999999997 108.751 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 304' ' ' ARG . . . . . 0.423 ' HE ' ' CG ' ' D' ' 264' ' ' ASN . 33.4 ptt180 -165.14 137.82 4.45 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.621 -0.832 . . . . 0.91000000000000003 110.388 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 305' ' ' LYS . . . . . 0.467 ' CB ' ' HZ1' ' D' ' 305' ' ' LYS . 0.0 OUTLIER -80.97 -45.41 16.69 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.6 -0.84 . . . . 1.04 109.655 179.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 306' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.23 153.92 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.117 -0.989 . . . . 1.1200000000000001 108.785 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 307' ' ' SER . . . . . . . . . . . . . 83.6 p -64.5 -16.37 62.41 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.937 -1.102 . . . . 1.1200000000000001 109.511 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 308' ' ' THR . . . . . 0.423 ' CG2' ' NH1' ' D' ' 181' ' ' ARG . 43.4 p -86.03 -8.97 57.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.06 -1.025 . . . . 1.3200000000000001 110.116 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 309' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -92.44 152.68 42.43 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.004 -1.06 . . . . 1.22 109.912 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 310' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.27 139.09 80.94 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.915 1.743 . . . . 1.3500000000000001 111.765 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 311' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -84.15 132.68 34.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.112 -0.992 . . . . 1.1299999999999999 109.832 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 312' ' ' LEU . . . . . . . . . . . . . 93.2 mt -117.31 154.91 30.42 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 1.1899999999999999 108.373 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 313' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -91.47 130.59 37.28 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.108 -0.995 . . . . 1.0900000000000001 109.78 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 314' ' ' MET . . . . . 0.615 ' SD ' ' CG2' ' D' ' 303' ' ' VAL . 8.2 tpt -56.55 -44.11 80.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.592 -0.693 . . . . 0.88 109.63 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 315' ' ' MET . . . . . 0.535 ' HG3' HD21 ' D' ' 295' ' ' ASN . 95.8 mmm -61.1 -40.51 94.01 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.553 -0.717 . . . . 1.02 110.235 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 316' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -61.76 -44.12 97.51 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.341 -0.849 . . . . 1.1299999999999999 109.758 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 317' ' ' LEU . . . . . . . . . . . . . 92.9 mt -66.47 -41.93 88.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -0.885 . . . . 1.1100000000000001 109.947 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 318' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.42 -24.32 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 1.1299999999999999 110.024 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 319' ' ' SER . . . . . 0.477 ' O ' ' C ' ' D' ' 323' ' ' LYS . 0.9 OUTLIER -72.77 -31.56 64.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 1.29 109.594 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 320' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -84.08 -2.56 56.94 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.844 -1.142 . . . . 1.3999999999999999 109.244 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 321' ' ' ILE . . . . . . . . . . . . . 93.2 mt -113.84 -58.63 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.022 -1.103 . . . . 1.3600000000000001 108.022 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 322' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' D' ' 323' ' ' LYS . 12.1 t0 -94.91 85.04 4.28 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.284 -1.747 . . . . 1.3100000000000001 106.284 178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 323' ' ' LYS . . . . . 1.183 ' NZ ' ' HA ' ' D' ' 323' ' ' LYS . 0.0 OUTLIER . . . . . 1 C--O 1.524 15.537 0 CA-C-O 126.343 2.973 . . . . 1.5900000000000001 109.42 -177.659 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.543 ' HB ' ' HG2' ' A' ' 105' ' ' ARG . 75.0 p . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 121.165 0.507 . . . . 0.87 110.931 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.633 ' O ' ' HD2' ' A' ' 105' ' ' ARG . 47.2 mt -71.53 136.24 26.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.658 -1.978 . . . . 0.78 105.658 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.93 144.72 36.6 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-N 115.246 -0.888 . . . . 0.67 110.557 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.5 mt -126.59 130.91 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.388 -0.968 . . . . 0.55 108.388 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.4 t -125.07 128.82 73.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 105.71 -1.959 . . . . 0.51 105.71 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.2 mt -108.69 132.72 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.24 -0.652 . . . . 0.35 109.24 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.81 134.17 6.8 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 120.036 -1.078 . . . . 0.3 111.093 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.687 HG21 ' HB3' ' A' ' 13' ' ' ALA . 14.4 t -142.13 165.72 26.68 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.101 -1.444 . . . . 0.36 107.101 177.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.599 ' ND1' ' OD2' ' A' ' 67' ' ' ASP . 72.9 m80 -68.58 151.95 46.05 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 102.343 -3.206 . . . . 1.57 102.343 174.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.32 -148.14 40.25 Favored Glycine 0 C--N 1.307 -1.03 0 C-N-CA 117.174 -2.441 . . . . 0.43 113.954 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -120.88 26.32 9.15 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.341 1.238 . . . . 0.77 114.341 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.687 ' HB3' HG21 ' A' ' 9' ' ' THR . . . -78.99 -26.93 43.32 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.945 1.461 . . . . 0.28 114.945 -178.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.36 -46.21 76.47 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.051 0.842 . . . . 0.27 112.321 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -60.0 -40.15 88.25 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.583 -0.447 . . . . 0.55 110.892 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -71.36 -34.19 70.24 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.325 0.861 . . . . 0.46 113.325 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.38 -38.77 91.03 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 106.719 -1.586 . . . . 0.34 106.719 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.1 tp -66.29 -43.84 85.18 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.5 -0.926 . . . . 0.46 108.5 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.694 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 24.3 mttm -60.99 -38.99 87.97 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 120.865 0.364 . . . . 0.57 111.101 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.6 m -64.53 -46.91 80.83 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 108.289 -1.004 . . . . 0.54 108.289 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.83 -44.24 90.86 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 119.898 -0.721 . . . . 0.61 110.755 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.877 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -68.46 -22.7 64.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.416 -0.356 . . . . 2.42 110.42 -178.764 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.468 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -71.1 -32.31 68.87 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.447 -2.057 . . . . 1.71 105.447 178.395 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.442 HD21 ' CE1' ' B' ' 10' ' ' HIS . 79.1 mt -84.32 -39.03 19.65 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.459 0.911 . . . . 0.8 113.459 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.487 HD11 HG13 ' A' ' 99' ' ' VAL . 96.1 mt -109.1 -11.9 14.88 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 118.568 2.803 . . . . 0.83 118.568 -175.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.42 165.64 30.93 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 105.21 -3.156 . . . . 0.81 105.21 -175.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -59.96 138.8 57.75 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.59 1.186 . . . . 0.87 112.162 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -105.53 147.12 28.71 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 112.874 -1.966 . . . . 0.72 112.901 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -106.15 158.46 16.82 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 113.949 -1.478 . . . . 0.95 107.537 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.7 t30 57.42 42.07 25.27 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.73 -1.123 . . . . 0.74 113.951 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.7 t -131.12 135.01 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.053 -1.092 . . . . 0.61 108.053 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.86 168.14 19.11 Favored Glycine 0 N--CA 1.476 1.307 0 N-CA-C 109.428 -1.469 . . . . 0.51 109.428 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -156.15 158.64 38.0 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 121.75 -0.853 . . . . 0.52 108.699 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 pt -137.68 160.03 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 115.416 -0.811 . . . . 0.51 109.454 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -115.06 163.41 15.65 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 108.533 -0.914 . . . . 0.58 108.533 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.429 ' CD1' ' C ' ' A' ' 36' ' ' PHE . 1.6 t80 -134.87 116.86 15.24 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 106.627 -1.619 . . . . 0.65 106.627 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.9 t -107.78 145.59 31.66 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 113.845 -1.525 . . . . 0.74 110.581 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -56.6 134.92 67.43 Favored 'Trans proline' 0 C--N 1.345 0.378 0 N-CA-C 108.292 -1.465 . . . . 0.84 108.292 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.46 -25.42 15.46 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.406 -1.478 . . . . 0.93 109.406 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -84.64 158.35 20.88 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.597 0.713 . . . . 0.84 109.611 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 50.8 p30 -125.89 179.47 5.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.937 -1.135 . . . . 2.42 107.937 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.84 -34.69 73.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.495 0.554 . . . . 0.8 112.495 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -65.48 -36.17 83.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.281 0.562 . . . . 2.93 111.681 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.4 m -63.66 -47.64 80.45 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.993 -1.855 . . . . 0.87 105.993 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.59 -36.37 83.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.186 -0.605 . . . . 0.73 112.433 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.9 -42.76 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.971 -1.122 . . . . 0.81 107.971 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -62.83 -42.55 99.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 120.014 -0.675 . . . . 0.93 110.381 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -62.45 -42.99 99.86 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 119.342 -0.943 . . . . 0.73 110.839 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -62.63 -45.4 93.0 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 108.677 -0.86 . . . . 0.66 108.677 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -60.71 -39.78 89.82 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.46 0.541 . . . . 0.83 112.46 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.82 79.34 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.344 -0.542 . . . . 0.79 109.829 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -71.06 -43.72 67.23 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 119.594 -0.842 . . . . 0.69 109.451 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.1 mt -60.0 -37.7 80.48 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 116.511 -0.313 . . . . 0.77 111.587 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.74 -25.8 29.98 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.222 0.453 . . . . 0.88 112.222 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -96.25 -4.68 41.9 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.04 -0.527 . . . . 0.81 112.394 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -105.61 158.64 16.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.714 0.635 . . . . 0.81 112.714 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -90.47 107.43 19.15 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 102.39 -3.189 . . . . 0.92 102.39 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -106.41 14.99 26.59 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 124.203 0.94 . . . . 0.83 110.842 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.3 p -63.71 -33.86 76.57 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 115.172 1.545 . . . . 0.97 115.172 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -92.81 -8.84 42.46 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 123.335 0.397 . . . . 1.02 111.463 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.67 172.03 12.98 Favored Glycine 0 C--N 1.314 -0.641 0 C-N-CA 119.351 -1.404 . . . . 0.8 112.892 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.1 t -139.04 130.86 36.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.004 0 N-CA-C 109.11 -0.7 . . . . 0.68 109.11 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 29.6 tp -116.57 114.99 24.9 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 125.323 1.64 . . . . 0.56 107.524 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -92.6 122.41 34.99 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 105.642 -1.984 . . . . 0.57 105.642 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.8 mt -109.72 114.99 29.03 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 104.644 -2.354 . . . . 0.4 104.644 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.06 163.71 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 121.706 0.765 . . . . 0.38 112.821 -176.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.599 ' OD2' ' ND1' ' A' ' 10' ' ' HIS . 12.1 p-10 -65.51 -54.66 24.98 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 117.117 2.266 . . . . 0.33 117.117 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.3 p -141.48 151.49 43.38 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 122.633 1.206 . . . . 0.45 112.652 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -65.86 134.36 52.87 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.791 -1.55 . . . . 0.72 108.013 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.85 -7.12 75.82 Favored Glycine 0 N--CA 1.468 0.781 0 N-CA-C 120.092 2.797 . . . . 0.67 120.092 176.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.36 174.83 55.0 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 119.686 1.743 . . . . 0.58 109.313 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.51 ' HB2' ' HD3' ' A' ' 73' ' ' PRO . 33.3 m -57.64 -47.22 99.34 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 122.185 -0.597 . . . . 1.42 111.734 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 72' ' ' SER . 85.2 Cg_exo -53.75 -41.76 71.7 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 N-CA-C 110.351 -0.673 . . . . 0.51 110.351 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -67.42 -48.67 66.64 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.531 0.519 . . . . 0.65 109.645 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.96 -42.47 94.14 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.648 0.981 . . . . 2.13 113.648 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.97 -42.9 84.36 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.366 -0.933 . . . . 0.67 111.232 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.97 -38.19 90.14 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.531 -0.914 . . . . 0.63 108.531 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.815 ' O ' HG13 ' A' ' 82' ' ' VAL . 4.0 m -59.33 -38.69 80.95 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.16 0.43 . . . . 1.52 112.16 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.452 HH11 ' HD3' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -68.78 -29.25 67.59 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.548 -0.461 . . . . 3.43 112.022 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.409 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 73.0 mt -77.25 -43.1 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 111.91 0.337 . . . . 0.78 111.91 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 87' ' ' TYR . 2.5 m -78.89 -17.52 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 115.441 1.645 . . . . 0.8 115.441 -175.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.815 HG13 ' O ' ' A' ' 78' ' ' SER . 30.5 m -29.09 -55.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 121.397 3.851 . . . . 0.94 121.397 -176.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.527 ' OD1' HG23 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -126.09 38.96 4.04 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 116.701 -2.0 . . . . 1.03 108.947 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -112.48 133.74 54.39 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.613 -1.176 . . . . 0.88 109.479 -179.472 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -78.65 141.6 37.85 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 106.674 -1.602 . . . . 1.03 106.674 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 61.1 m170 62.43 35.33 14.9 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 114.386 1.254 . . . . 0.95 114.386 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.488 ' HB3' ' HB ' ' A' ' 81' ' ' VAL . 6.2 m-85 -128.63 129.88 46.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 105.25 -2.13 . . . . 0.77 105.25 175.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -145.49 156.26 43.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.173 -0.611 . . . . 0.7 110.226 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.3 t -122.67 128.76 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 N-CA-C 105.623 -1.991 . . . . 0.57 105.623 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.1 mt -124.73 120.77 59.67 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 N-CA-C 107.496 -1.298 . . . . 0.54 107.496 177.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.33 164.16 17.25 Favored 'General case' 0 CA--C 1.571 1.772 0 CA-C-N 114.571 -1.195 . . . . 0.45 111.095 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.19 24.45 57.24 Favored Glycine 0 C--O 1.222 -0.639 0 CA-C-N 115.684 -0.689 . . . . 0.36 114.512 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.8 p -48.64 132.88 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 112.91 0.707 . . . . 0.28 112.91 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' B' ' 94' ' ' ASN . 52.4 p30 -142.11 170.24 16.09 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.512 -1.292 . . . . 0.44 107.512 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.8 mm -61.64 -42.68 85.03 Favored Pre-proline 0 C--O 1.243 0.734 0 N-CA-C 113.771 1.026 . . . . 0.47 113.771 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.415 ' HD2' ' CG ' ' A' ' 94' ' ' ASN . 24.9 Cg_exo -57.06 -43.82 50.11 Favored 'Trans proline' 0 CA--C 1.552 1.403 0 CA-C-N 119.732 0.94 . . . . 0.56 110.113 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 40.4 ttm -61.4 -48.88 79.19 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 120.177 -0.609 . . . . 0.51 109.642 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.6 tp -61.18 -47.52 85.78 Favored 'General case' 0 C--O 1.203 -1.349 0 C-N-CA 120.344 -0.543 . . . . 0.52 112.118 -177.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.487 HG13 HD11 ' A' ' 25' ' ' LEU . 85.9 t -62.37 -49.25 84.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 112.36 0.504 . . . . 0.66 112.36 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.76 ' CA ' ' OE1' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -63.93 -40.9 97.53 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.256 -0.577 . . . . 2.05 111.213 -179.215 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.5 m -65.94 -45.7 80.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.825 -0.625 . . . . 0.67 110.89 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.6 mt -65.25 -37.49 87.4 Favored 'General case' 0 CA--C 1.551 1.0 0 O-C-N 123.518 0.511 . . . . 0.74 110.018 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.489 ' HE3' ' HB3' ' A' ' 103' ' ' MET . 3.0 mtp -66.32 -45.92 78.62 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.429 -0.794 . . . . 1.08 111.699 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.401 ' O ' ' HD3' ' A' ' 109' ' ' PRO . . . -67.72 -33.69 75.38 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.897 0.703 . . . . 0.88 112.897 -177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.633 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 17.6 ttp180 -53.03 -32.9 49.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.873 -0.603 . . . . 0.86 112.599 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.19 -19.8 61.03 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 113.598 0.962 . . . . 2.35 113.598 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -90.61 18.23 6.59 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 121.906 0.86 . . . . 2.28 109.302 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.9 t70 46.82 59.2 16.48 Favored Pre-proline 0 C--N 1.313 -1.009 0 N-CA-C 116.174 1.916 . . . . 1.06 116.174 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.405 ' HG3' HD13 ' A' ' 114' ' ' LEU . 46.9 Cg_endo -73.8 168.92 23.59 Favored 'Trans proline' 0 C--O 1.207 -1.048 0 C-N-CA 120.966 1.111 . . . . 0.95 110.432 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.7 p -78.05 163.12 26.19 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 106.245 -1.761 . . . . 0.99 106.245 175.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -56.66 -51.32 69.17 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-O 119.105 -0.474 . . . . 0.88 111.83 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -59.15 -36.29 75.01 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.784 0.72 . . . . 0.97 112.607 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -64.74 -45.81 84.9 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.4 -0.593 . . . . 1.07 109.4 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.405 HD13 ' HG3' ' A' ' 109' ' ' PRO . 15.6 tp -65.33 -45.07 85.73 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 120.757 -0.377 . . . . 0.8 110.728 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.78 -47.8 85.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.335 -0.546 . . . . 0.71 109.962 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.67 -43.23 97.92 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 120.878 0.371 . . . . 0.85 111.944 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.9 tp -63.76 -42.31 97.83 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 119.495 -0.288 . . . . 0.83 110.376 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.78 -44.39 96.85 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.831 -0.748 . . . . 0.66 111.861 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.43 -46.32 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 109.295 -0.632 . . . . 0.68 109.295 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -63.58 -45.58 89.78 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.06 0.763 . . . . 0.93 113.06 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 57.6 p -71.79 -31.5 66.66 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 120.335 -0.546 . . . . 0.74 111.701 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.12 -45.83 94.58 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 108.795 -1.722 . . . . 0.59 108.795 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.5 mtp-105 -72.63 -41.7 65.22 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.228 0.455 . . . . 0.82 112.228 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -70.65 -19.86 62.77 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.536 -0.866 . . . . 2.54 111.502 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.42 -16.33 77.36 Favored Glycine 0 CA--C 1.535 1.29 0 O-C-N 124.041 0.838 . . . . 0.67 112.826 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.0 t -89.73 111.59 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 106.452 -1.684 . . . . 0.74 106.452 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -154.66 138.1 15.88 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.835 -0.802 . . . . 2.84 108.835 -173.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.33 147.53 23.4 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.044 0.926 . . . . 0.92 109.494 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 130' ' ' LYS . 41.8 tp -67.81 -57.94 5.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.071 -0.968 . . . . 1.03 110.7 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 129' ' ' LEU . 76.0 mttt . . . . . 1 C--O 1.433 10.715 1 CA-C-O 145.741 12.21 . . . . 2.77 110.634 177.727 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' B' B ' 2' ' ' THR . . . . . 0.526 ' HB ' ' HG2' ' B' ' 105' ' ' ARG . 76.1 p . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.185 0.517 . . . . 0.95 110.955 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ILE . . . . . 0.623 ' O ' ' HD2' ' B' ' 105' ' ' ARG . 47.1 mt -71.46 136.28 26.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 105.676 -1.972 . . . . 0.91 105.676 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.1 144.7 36.27 Favored 'General case' 0 C--O 1.209 -1.078 0 CA-C-N 115.319 -0.855 . . . . 0.81 110.52 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 40.8 mt -126.53 130.91 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 108.436 -0.95 . . . . 0.68 108.436 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 92.3 t -125.08 128.81 73.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 105.711 -1.959 . . . . 0.68 105.711 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 38.2 mt -108.66 132.72 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.27 -0.641 . . . . 0.52 109.27 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.67 133.94 6.69 Favored Glycine 0 N--CA 1.472 1.084 0 C-N-CA 120.086 -1.054 . . . . 0.51 110.846 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.742 HG21 ' HB3' ' B' ' 13' ' ' ALA . 14.9 t -146.0 162.07 38.68 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.209 -1.404 . . . . 0.53 107.209 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' HIS . . . . . 0.442 ' CE1' HD21 ' A' ' 24' ' ' LEU . 3.1 m-70 -68.62 144.03 54.63 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 102.948 -2.982 . . . . 1.33 102.948 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.83 -141.96 26.01 Favored Glycine 0 C--N 1.306 -1.108 0 C-N-CA 117.237 -2.411 . . . . 0.56 114.109 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -123.5 26.16 7.94 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 113.945 1.091 . . . . 0.85 113.945 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.742 ' HB3' HG21 ' B' ' 9' ' ' THR . . . -79.16 -26.77 42.71 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.898 1.444 . . . . 0.38 114.898 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.36 -46.18 76.48 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.154 0.888 . . . . 0.4 112.379 -176.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -59.98 -40.16 88.15 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.485 -0.486 . . . . 0.56 110.928 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.31 -34.27 70.45 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.34 0.867 . . . . 0.45 113.34 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 85.4 mt -65.34 -38.79 91.2 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 106.706 -1.59 . . . . 0.31 106.706 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 18.9 tp -66.27 -43.81 85.41 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.537 -0.912 . . . . 0.5 108.537 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -61.02 -39.01 88.13 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.923 0.392 . . . . 0.55 111.092 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 16.7 m -64.49 -46.9 81.01 Favored 'General case' 0 C--O 1.248 1.026 0 N-CA-C 108.268 -1.012 . . . . 0.43 108.268 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.83 -44.21 90.87 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 119.875 -0.73 . . . . 0.52 110.841 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 1.293 ' OE2' ' HG2' ' B' ' 27' ' ' GLU . 15.0 tt0 -68.52 -22.63 64.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.345 -0.388 . . . . 2.39 110.478 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -32.27 68.69 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 105.448 -2.056 . . . . 1.71 105.448 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 81.1 mt -84.15 -39.07 19.87 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.522 0.934 . . . . 0.68 113.522 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.488 HD11 HG13 ' B' ' 99' ' ' VAL . 95.4 mt -109.12 -11.82 14.89 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 118.636 2.828 . . . . 0.75 118.636 -175.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' B' ' 22' ' ' GLU . . . 98.37 165.67 31.0 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 105.247 -3.141 . . . . 0.74 105.247 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLU . . . . . 1.293 ' HG2' ' OE2' ' B' ' 22' ' ' GLU . 40.4 mt-10 -59.88 138.84 57.71 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 122.609 1.195 . . . . 0.82 112.217 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -105.62 147.06 28.87 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 112.913 -1.949 . . . . 0.71 112.918 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -106.22 158.44 16.84 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.952 -1.476 . . . . 0.95 107.47 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 29.9 t30 57.43 42.07 25.24 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.64 -1.164 . . . . 0.84 113.9 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 94.1 t -131.02 135.03 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.115 -1.069 . . . . 0.68 108.115 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.85 168.19 19.07 Favored Glycine 0 N--CA 1.477 1.38 0 N-CA-C 109.404 -1.478 . . . . 0.61 109.404 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -156.12 158.61 37.99 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.783 -0.821 . . . . 0.61 108.783 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 pt -137.67 160.0 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 O-C-N 124.002 0.814 . . . . 0.67 109.403 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -114.98 163.41 15.62 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 108.493 -0.929 . . . . 0.68 108.493 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' B' ' 36' ' ' PHE . 1.6 t80 -134.91 116.91 15.27 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.605 -1.628 . . . . 0.82 106.605 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 95.9 t -107.83 145.55 31.6 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 113.876 -1.511 . . . . 0.85 110.601 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -56.6 134.98 67.83 Favored 'Trans proline' 0 C--N 1.346 0.446 0 N-CA-C 108.302 -1.461 . . . . 0.95 108.302 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.41 -25.3 15.83 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.415 -1.474 . . . . 1.06 109.415 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -84.61 158.31 20.92 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.583 0.706 . . . . 0.97 109.592 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -125.86 179.44 5.19 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.952 -1.129 . . . . 2.47 107.952 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.92 -34.57 73.4 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.538 0.57 . . . . 1.0 112.538 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.43 -36.3 83.51 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.261 0.553 . . . . 3.02 111.66 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 88.4 m -63.6 -47.58 80.84 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 106.033 -1.84 . . . . 1.02 106.033 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 35.0 mt -63.62 -36.48 83.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.213 -0.595 . . . . 0.9 112.344 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.86 -42.75 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 107.948 -1.131 . . . . 1.04 107.948 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -62.89 -42.56 99.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 120.046 -0.662 . . . . 1.09 110.304 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -62.35 -43.09 99.65 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 119.348 -0.941 . . . . 0.88 110.906 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -62.49 -45.43 93.05 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 108.719 -0.845 . . . . 0.83 108.719 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -60.73 -39.82 90.06 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.383 0.512 . . . . 1.02 112.383 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.05 -34.82 79.33 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.34 -0.544 . . . . 0.9 109.802 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -70.99 -43.79 67.28 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 119.589 -0.844 . . . . 0.82 109.437 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.97 -37.7 80.4 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.52 -0.309 . . . . 0.9 111.582 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.72 -25.77 29.6 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.257 0.466 . . . . 0.98 112.257 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -96.27 -4.63 41.92 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 112.397 0.517 . . . . 0.91 112.397 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 74.6 mt -105.6 158.5 16.65 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.748 0.648 . . . . 0.94 112.748 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -90.36 107.42 19.14 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 102.382 -3.192 . . . . 1.02 102.382 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 73.4 p -106.53 15.07 26.32 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 124.267 0.979 . . . . 1.01 110.826 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 72.1 p -63.6 -33.94 76.72 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 115.249 1.574 . . . . 1.12 115.249 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -92.82 -8.87 42.33 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.394 0.434 . . . . 1.14 111.41 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.71 172.04 12.98 Favored Glycine 0 C--N 1.314 -0.683 0 C-N-CA 119.341 -1.409 . . . . 0.98 112.882 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 58.6 t -138.95 130.82 36.42 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 109.17 -0.678 . . . . 0.88 109.17 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 29.6 tp -116.48 115.0 24.98 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 125.325 1.64 . . . . 0.76 107.508 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -92.57 122.34 34.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 105.637 -1.986 . . . . 0.8 105.637 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 83.0 mt -109.66 114.98 29.04 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 104.636 -2.357 . . . . 0.57 104.636 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.07 163.86 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 121.67 0.748 . . . . 0.61 112.752 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' B' ' 67' ' ' ASP . 12.5 p-10 -65.62 -54.55 26.22 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 117.193 2.294 . . . . 0.53 117.193 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 74.5 p -141.57 151.48 43.23 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.57 1.176 . . . . 0.67 112.7 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -65.98 134.4 52.86 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 113.77 -1.559 . . . . 0.97 107.959 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.79 -7.04 75.89 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 120.137 2.815 . . . . 0.89 120.137 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.4 174.84 54.99 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 119.607 1.704 . . . . 0.81 109.356 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.496 ' HB2' ' HD3' ' B' ' 73' ' ' PRO . 20.4 m -57.58 -47.23 99.33 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 122.131 -0.629 . . . . 1.52 111.755 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' B' ' 72' ' ' SER . 85.7 Cg_exo -53.74 -41.81 71.26 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 N-CA-C 110.327 -0.682 . . . . 0.73 110.327 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -67.4 -48.66 66.72 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.531 0.52 . . . . 0.9 109.605 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -60.0 -42.48 94.35 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.689 0.996 . . . . 2.24 113.689 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.91 84.97 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.322 -0.951 . . . . 0.91 111.401 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.18 90.04 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.553 -0.906 . . . . 0.89 108.553 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.801 ' O ' HG13 ' B' ' 82' ' ' VAL . 3.4 m -59.28 -38.84 81.13 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.121 0.415 . . . . 1.62 112.121 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.532 ' O ' HG22 ' B' ' 82' ' ' VAL . 3.6 mtt180 -68.61 -29.33 67.82 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.617 -0.433 . . . . 3.5 112.106 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 72.8 mt -77.24 -42.98 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 111.943 0.349 . . . . 1.04 111.943 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' B' ' 87' ' ' TYR . 2.5 m -78.93 -17.6 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 115.438 1.644 . . . . 1.07 115.438 -175.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' VAL . . . . . 0.801 HG13 ' O ' ' B' ' 78' ' ' SER . 10.5 m -29.11 -55.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 121.398 3.851 . . . . 1.2 121.398 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.04 38.97 4.04 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 116.708 -1.997 . . . . 1.32 109.057 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.48 133.71 54.4 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.62 -1.173 . . . . 1.16 109.514 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -78.68 141.59 37.82 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.666 -1.605 . . . . 1.29 106.666 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 61.0 m170 62.45 35.23 14.89 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 114.435 1.272 . . . . 1.16 114.435 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' TYR . . . . . 0.492 ' HB3' ' HB ' ' B' ' 81' ' ' VAL . 6.2 m-85 -128.46 129.95 46.85 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.257 -2.127 . . . . 0.99 105.257 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -145.61 156.18 43.51 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.181 -0.608 . . . . 0.93 110.293 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 19.1 t -122.6 128.7 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 N-CA-C 105.638 -1.986 . . . . 0.82 105.638 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 34.2 mt -124.7 120.75 59.65 Favored 'Isoleucine or valine' 0 C--O 1.251 1.167 0 N-CA-C 107.536 -1.283 . . . . 0.71 107.536 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.35 164.08 17.28 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 114.616 -1.175 . . . . 0.65 111.087 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.37 24.31 57.02 Favored Glycine 0 CA--C 1.502 -0.772 0 CA-C-N 115.608 -0.724 . . . . 0.53 114.569 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 11.9 p -48.67 132.98 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 112.903 0.705 . . . . 0.43 112.903 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' A' ' 94' ' ' ASN . 52.6 p30 -142.22 170.14 16.28 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.503 -1.295 . . . . 0.4 107.503 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.418 ' HA ' HD13 ' B' ' 95' ' ' ILE . 46.8 mm -61.65 -42.56 84.38 Favored Pre-proline 0 C--O 1.243 0.72 0 N-CA-C 113.833 1.049 . . . . 0.39 113.833 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' B' ' 94' ' ' ASN . 24.7 Cg_exo -57.12 -43.79 50.0 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 CA-C-N 119.726 0.938 . . . . 0.51 110.091 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 40.4 ttm -61.42 -48.84 79.34 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 120.289 -0.564 . . . . 0.52 109.596 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 14.6 tp -61.21 -47.58 85.47 Favored 'General case' 0 C--O 1.205 -1.286 0 C-N-CA 120.371 -0.532 . . . . 0.51 112.095 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' VAL . . . . . 0.488 HG13 HD11 ' B' ' 25' ' ' LEU . 93.7 t -62.36 -49.24 84.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 112.385 0.513 . . . . 0.61 112.385 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.592 ' HA ' ' OE1' ' B' ' 100' ' ' GLU . 0.1 OUTLIER -63.91 -40.91 97.57 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.216 -0.594 . . . . 2.06 111.159 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 101' ' ' THR . . . . . . . . . . . . . 54.0 m -66.06 -45.65 80.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.87 -0.605 . . . . 0.7 110.852 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 97.5 mt -65.15 -37.5 87.61 Favored 'General case' 0 CA--C 1.551 0.991 0 O-C-N 123.563 0.539 . . . . 0.74 110.014 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' MET . . . . . . . . . . . . . 2.3 mtm -66.34 -45.91 78.63 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 121.369 -0.832 . . . . 1.05 111.766 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.418 ' O ' ' HD3' ' B' ' 109' ' ' PRO . . . -67.81 -33.64 75.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.904 0.705 . . . . 0.9 112.904 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.623 ' HD2' ' O ' ' B' ' 3' ' ' ILE . 13.0 ttp180 -53.04 -32.86 49.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.86 -0.609 . . . . 0.91 112.632 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.21 -19.77 61.01 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 113.728 1.011 . . . . 2.35 113.728 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -90.54 18.19 6.56 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.805 0.812 . . . . 2.29 109.271 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 13.9 t70 46.86 59.12 16.62 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 116.232 1.938 . . . . 1.15 116.232 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' B' ' 104' ' ' ALA . 47.3 Cg_endo -73.79 168.86 23.74 Favored 'Trans proline' 0 C--O 1.207 -1.06 0 C-N-CA 120.981 1.121 . . . . 1.04 110.427 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 54.5 p -77.87 163.17 26.29 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 106.351 -1.722 . . . . 1.13 106.351 175.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -56.78 -51.18 69.94 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 119.059 -0.496 . . . . 1.04 111.855 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -59.31 -36.28 75.34 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.817 0.735 . . . . 1.17 112.5 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -64.71 -45.84 84.83 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.331 -0.618 . . . . 1.17 109.331 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.414 HD13 ' HG3' ' B' ' 109' ' ' PRO . 15.6 tp -65.43 -44.91 85.87 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 120.711 -0.396 . . . . 0.92 110.763 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.79 -47.81 85.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.382 -0.527 . . . . 0.88 109.994 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.26 97.84 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 111.958 0.355 . . . . 0.96 111.958 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.74 -42.28 97.9 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 119.444 -0.312 . . . . 0.85 110.363 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.7 -44.49 96.5 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.876 -0.729 . . . . 0.73 111.875 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.43 -46.27 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.313 -0.625 . . . . 0.79 109.313 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -63.58 -45.54 89.96 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.137 0.792 . . . . 0.95 113.137 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 57.5 p -71.75 -31.53 66.76 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 120.38 -0.528 . . . . 0.7 111.774 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.12 -45.78 94.7 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 108.86 -1.696 . . . . 0.59 108.86 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 9.2 mtp-105 -72.65 -41.72 65.16 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 112.213 0.449 . . . . 0.86 112.213 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -70.59 -19.82 62.82 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.468 -0.893 . . . . 2.5 111.576 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.52 -16.31 77.55 Favored Glycine 0 CA--C 1.534 1.223 0 O-C-N 124.105 0.878 . . . . 0.59 112.829 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 94.3 t -89.66 111.63 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 106.453 -1.684 . . . . 0.62 106.453 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -154.69 138.02 15.79 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.861 -0.792 . . . . 2.73 108.861 -173.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.31 147.53 23.39 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 122.036 0.922 . . . . 0.69 109.482 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' B' ' 130' ' ' LYS . 41.9 tp -67.9 -58.12 5.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.114 -0.948 . . . . 0.78 110.653 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' B' ' 129' ' ' LEU . 76.5 mttt . . . . . 1 C--O 1.433 10.713 1 CA-C-O 145.661 12.172 . . . . 2.73 110.616 177.829 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' D' D ' 159' ' ' ASN . . . . . 0.551 ' OD1' ' NZ ' ' D' ' 259' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 108.988 -0.745 . . . . 1.37 108.988 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 160' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -85.89 25.54 1.1 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.449 -0.945 . . . . 1.65 108.449 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 161' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -118.62 -141.9 0.36 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.619 -0.882 . . . . 1.61 108.619 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 162' ' ' MET . . . . . 0.584 ' SD ' HG21 ' D' ' 240' ' ' VAL . 0.3 OUTLIER -61.75 156.13 21.1 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.895 -1.128 . . . . 1.25 110.492 -178.74 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 163' ' ' VAL . . . . . . . . . . . . . 93.2 t -113.04 117.76 56.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 109.142 -0.688 . . . . 1.23 109.142 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 164' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.66 103.33 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.56 -0.904 . . . . 0.96 108.56 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.65 -35.2 80.1 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.121 -1.592 . . . . 0.89 109.121 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 tp -172.13 147.94 2.13 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.86 -1.136 . . . . 0.76 111.27 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 167' ' ' ALA . . . . . . . . . . . . . . . -117.68 104.14 10.71 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.167 -0.679 . . . . 0.58 109.167 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 168' ' ' ARG . . . . . 0.868 ' NH1' HG12 ' D' ' 178' ' ' VAL . 44.4 ttp180 -106.2 126.01 51.69 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.923 0.868 . . . . 0.57 110.983 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 169' ' ' ILE . . . . . . . . . . . . . 82.1 mt -95.55 129.27 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 109.183 -0.673 . . . . 0.37 109.183 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 170' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -165.88 117.07 1.05 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.417 -0.802 . . . . 0.43 110.349 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 171' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -62.89 -10.07 12.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.564 -0.71 . . . . 0.5 109.794 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 172' ' ' ARG . . . . . 0.68 ' NH2' ' CE1' ' D' ' 175' ' ' HIS . 88.0 mtm180 -101.7 -3.9 27.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.905 -1.122 . . . . 0.7 110.418 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 173' ' ' LEU . . . . . 0.771 HD12 ' N ' ' D' ' 173' ' ' LEU . 6.8 mp 56.06 -99.77 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 120.101 -0.64 . . . . 0.39 109.372 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 174' ' ' ILE . . . . . . . . . . . . . 96.5 mt -105.66 113.58 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.017 -1.052 . . . . 0.59 109.32 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 175' ' ' HIS . . . . . 0.68 ' CE1' ' NH2' ' D' ' 172' ' ' ARG . 10.4 p80 -142.01 120.7 12.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.251 -0.905 . . . . 0.7 108.648 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 176' ' ' GLY . . . . . . . . . . . . . . . 79.95 -141.18 23.12 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 110.027 -1.229 . . . . 0.84 110.027 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 177' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' D' ' 178' ' ' VAL . 4.7 pt20 -113.04 4.76 16.84 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.427 -0.953 . . . . 1.19 108.427 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 178' ' ' VAL . . . . . 0.868 HG12 ' NH1' ' D' ' 168' ' ' ARG . 38.1 t -48.22 -42.61 11.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 117.499 -1.68 . . . . 0.82 108.597 171.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 179' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' D' ' 183' ' ' THR . . . -73.24 -36.34 66.42 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.002 -1.061 . . . . 0.81 110.142 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 180' ' ' THR . . . . . . . . . . . . . 21.7 m -66.28 -54.73 21.43 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.77 -0.772 . . . . 1.06 109.671 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 181' ' ' ARG . . . . . 0.626 HH12 HG21 ' D' ' 308' ' ' THR . 73.6 ttt180 -64.59 -43.73 92.9 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.624 -0.672 . . . . 1.3 110.583 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 182' ' ' TRP . . . . . 0.544 ' O ' HG23 ' D' ' 186' ' ' THR . 19.6 m95 -65.85 -32.04 73.34 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.131 -0.981 . . . . 0.9 109.589 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 183' ' ' THR . . . . . 0.834 HG21 HG21 ' D' ' 216' ' ' VAL . 69.3 m -65.4 -46.99 77.86 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.926 -1.108 . . . . 1.04 110.166 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 184' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -69.93 -42.77 72.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.148 -0.97 . . . . 1.41 110.656 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 185' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -68.41 -39.53 81.59 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.806 -1.184 . . . . 1.29 109.615 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 186' ' ' THR . . . . . 0.544 HG23 ' O ' ' D' ' 182' ' ' TRP . 72.9 p -81.32 -1.39 45.09 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.2 -0.937 . . . . 1.05 109.682 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 187' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 52.18 48.4 22.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.087 -1.008 . . . . 1.37 108.637 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 188' ' ' VAL . . . . . . . . . . . . . 47.8 t -104.97 133.54 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.146 -0.971 . . . . 1.05 110.027 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 189' ' ' SER . . . . . . . . . . . . . 27.4 p -109.78 -6.44 15.27 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.804 -0.813 . . . . 1.19 108.804 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 190' ' ' ARG . . . . . . . . . . . . . 29.3 mtt-85 -135.84 142.92 44.87 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.484 0.659 . . . . 1.3 110.41 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 191' ' ' ILE . . . . . . . . . . . . . 87.5 mt -133.3 127.46 54.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.243 -1.021 . . . . 0.8 108.243 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 192' ' ' ILE . . . . . 0.454 HD12 HG11 ' D' ' 240' ' ' VAL . 97.1 mt -115.48 128.86 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.205 -0.934 . . . . 0.85 109.734 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 193' ' ' VAL . . . . . . . . . . . . . 53.8 t -99.86 129.1 51.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.711 -0.848 . . . . 0.57 108.711 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 194' ' ' VAL . . . . . . . . . . . . . 42.5 t -112.75 103.75 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.487 -0.758 . . . . 0.61 109.334 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 195' ' ' SER . . . . . . . . . . . . . 37.5 t -167.36 125.69 1.29 Allowed 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.301 -0.96 . . . . 0.61 109.276 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 196' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.23 -34.76 66.07 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.512 -0.742 . . . . 0.87 109.791 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 197' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -65.66 -45.37 83.21 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.021 -1.049 . . . . 0.73 109.991 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 198' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.26 -43.0 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.16 -0.962 . . . . 0.62 109.062 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.63 -26.53 56.14 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.681 -0.807 . . . . 0.8 109.151 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 200' ' ' ALA . . . . . . . . . . . . . . . -84.9 -5.34 59.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.986 -1.071 . . . . 0.84 109.905 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 201' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -102.87 95.38 6.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.901 -1.124 . . . . 0.72 109.546 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 202' ' ' THR . . . . . . . . . . . . . 61.2 p -66.11 -33.17 75.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 1.48 110.583 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 203' ' ' VAL . . . . . . . . . . . . . 65.6 t -66.54 -47.35 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.769 -1.207 . . . . 0.81 109.472 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 204' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -63.87 -42.16 97.59 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.348 -0.941 . . . . 0.63 109.453 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 205' ' ' LYS . . . . . 0.51 ' O ' HG23 ' D' ' 209' ' ' THR . 86.6 tttt -58.11 -42.36 85.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.092 -1.005 . . . . 0.89 109.338 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 206' ' ' THR . . . . . . . . . . . . . 99.2 m -60.63 -48.82 80.08 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.098 -1.041 . . . . 0.82 109.528 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 207' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.7 -44.25 96.72 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.92 -1.113 . . . . 0.77 110.81 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 208' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' D' ' 208' ' ' LEU . 82.1 mt -62.6 -41.5 99.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.693 -1.254 . . . . 0.67 110.145 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 209' ' ' THR . . . . . 0.51 HG23 ' O ' ' D' ' 205' ' ' LYS . 73.6 p -67.72 -31.86 72.09 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.429 -0.794 . . . . 0.85 110.31 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 210' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -80.42 -17.61 51.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.787 -1.196 . . . . 2.5 110.808 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 211' ' ' VAL . . . . . . . . . . . . . 17.6 m -107.61 17.52 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.09 -1.006 . . . . 0.82 108.77 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.04 123.42 82.03 Favored Pre-proline 0 N--CA 1.482 1.134 0 N-CA-C 107.868 -1.16 . . . . 0.95 107.868 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 213' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -44.29 144.51 2.9 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 122.11 1.873 . . . . 1.03 112.688 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 214' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.46 134.85 66.95 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.161 1.907 . . . . 1.24 112.146 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . 79.82 -8.58 49.19 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.024 -1.231 . . . . 1.25 110.024 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 216' ' ' VAL . . . . . 0.834 HG21 HG21 ' D' ' 183' ' ' THR . 56.0 t -114.66 136.82 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -1.105 . . . . 1.1 108.94 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 217' ' ' THR . . . . . . . . . . . . . 6.8 p -104.84 135.74 45.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.431 -0.793 . . . . 1.1 109.921 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 218' ' ' ALA . . . . . . . . . . . . . . . -110.11 131.28 55.2 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.175 -1.046 . . . . 0.83 108.175 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 219' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -120.95 153.51 37.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.457 -0.777 . . . . 1.01 109.734 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 65.9 t -126.44 117.91 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.649 0.738 . . . . 0.8 109.09 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 221' ' ' VAL . . . . . . . . . . . . . 31.3 m -140.92 165.11 20.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.516 -0.74 . . . . 0.87 109.512 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 222' ' ' ASP . . . . . 0.712 ' OD1' ' N ' ' D' ' 225' ' ' LYS . 6.6 p30 -94.24 167.02 11.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.493 -0.754 . . . . 1.0 109.305 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 69.0 t -57.38 -44.73 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.049 -1.032 . . . . 0.92 110.429 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 224' ' ' ALA . . . . . 0.857 ' O ' HG22 ' D' ' 227' ' ' ILE . . . -62.79 -44.81 95.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.005 -1.06 . . . . 1.11 109.353 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 225' ' ' LYS . . . . . 0.712 ' N ' ' OD1' ' D' ' 222' ' ' ASP . 45.7 tttm -68.26 -35.06 77.32 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.863 -1.148 . . . . 1.14 109.58 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 226' ' ' MET . . . . . . . . . . . . . 10.3 tpt -62.22 -40.36 95.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.015 -1.053 . . . . 0.99 111.124 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 227' ' ' ILE . . . . . 0.857 HG22 ' O ' ' D' ' 224' ' ' ALA . 17.3 tt -60.85 -34.59 59.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.683 -0.858 . . . . 1.17 108.683 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 228' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.52 -38.9 62.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.802 -0.561 . . . . 1.53 110.913 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.22 -41.66 92.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.8 -1.185 . . . . 1.21 107.8 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 230' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' D' ' 230' ' ' TYR . 36.9 t80 -67.24 -32.07 72.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.08 -1.013 . . . . 1.25 109.788 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 231' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.77 6.8 2.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.055 -1.028 . . . . 1.48 110.113 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 232' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -110.35 117.69 50.77 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.134 -0.979 . . . . 1.54 109.366 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 233' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -64.97 0.5 2.51 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.608 1.539 . . . . 1.64 111.932 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 234' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -59.99 -24.56 64.55 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.056 -1.028 . . . . 1.56 108.8 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 235' ' ' TYR . . . . . 0.51 ' O ' ' HB2' ' D' ' 238' ' ' GLU . 81.1 m-85 -105.58 15.75 26.51 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.57 -0.852 . . . . 1.4 108.988 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.74 135.79 46.84 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.055 -1.653 . . . . 1.51 109.655 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.61 -33.42 1.86 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.339 -1.504 . . . . 1.4 109.339 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 238' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' D' ' 235' ' ' TYR . 4.0 mm-40 -54.27 138.97 37.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.823 -1.398 . . . . 1.37 109.367 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 239' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -99.11 116.29 30.98 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.443 -0.947 . . . . 1.37 108.443 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 240' ' ' VAL . . . . . 0.584 HG21 ' SD ' ' D' ' 162' ' ' MET . 26.3 t -121.83 148.68 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.829 0.823 . . . . 0.99 110.492 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 241' ' ' MET . . . . . . . . . . . . . 13.7 ttm -102.7 134.81 45.47 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.008 -1.108 . . . . 0.76 108.008 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 242' ' ' LEU . . . . . 0.404 ' HB3' ' CE2' ' D' ' 244' ' ' PHE . 61.0 mt -102.0 127.24 48.96 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.949 0.88 . . . . 0.67 109.878 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 243' ' ' LEU . . . . . . . . . . . . . 97.5 mt -109.27 126.05 52.93 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.877 0.846 . . . . 0.41 109.155 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 244' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' D' ' 242' ' ' LEU . 77.6 m-85 -127.02 161.99 27.07 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.78 0.8 . . . . 0.5 109.4 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 245' ' ' THR . . . . . . . . . . . . . 69.4 p -109.44 -19.55 13.21 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.748 0.785 . . . . 0.38 109.012 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 246' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' D' ' 246' ' ' ASN . 17.2 p30 -151.01 141.73 14.84 Favored Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 119.935 -0.706 . . . . 0.54 109.912 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 247' ' ' PRO . . . . . 0.459 ' HG3' ' CE2' ' D' ' 291' ' ' PHE . 7.4 Cg_endo -60.71 -14.53 32.14 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.627 2.218 . . . . 0.57 112.185 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 248' ' ' THR . . . . . . . . . . . . . 96.1 m -65.14 -42.66 93.6 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.435 -0.95 . . . . 0.77 108.435 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 249' ' ' ASP . . . . . 0.429 ' O ' HD12 ' D' ' 253' ' ' LEU . 97.8 m-20 -67.33 -23.37 65.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.566 -0.709 . . . . 0.64 109.85 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 250' ' ' VAL . . . . . . . . . . . . . 98.4 t -73.97 -43.69 51.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.589 -1.319 . . . . 0.68 109.697 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 251' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -62.37 -35.0 77.79 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.229 -0.988 . . . . 0.93 108.491 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 252' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -62.34 -44.16 97.13 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.335 -0.853 . . . . 1.01 110.193 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 253' ' ' LEU . . . . . 0.429 HD12 ' O ' ' D' ' 249' ' ' ASP . 1.2 mp -64.08 -40.32 96.0 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.881 -1.528 . . . . 0.93 108.867 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 254' ' ' VAL . . . . . 0.574 ' CG2' HD12 ' D' ' 260' ' ' ILE . 70.8 t -60.78 -44.59 97.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.715 -1.24 . . . . 1.01 108.905 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 255' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.37 -30.86 69.84 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.899 -1.126 . . . . 1.17 109.906 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 256' ' ' GLY . . . . . . . . . . . . . . . -74.37 2.91 43.41 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.544 -1.422 . . . . 1.2 109.544 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.46 15.81 45.55 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.599 -1.401 . . . . 1.16 109.599 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 258' ' ' VAL . . . . . . . . . . . . . 95.6 t -77.91 139.7 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 106.886 -1.524 . . . . 1.03 106.886 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 259' ' ' LYS . . . . . 0.551 ' NZ ' ' OD1' ' D' ' 159' ' ' ASN . 17.7 tttt -98.97 123.74 43.46 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.972 -1.08 . . . . 1.2 110.912 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 260' ' ' ILE . . . . . 0.574 HD12 ' CG2' ' D' ' 254' ' ' VAL . 98.1 mt -130.09 125.42 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.537 -0.727 . . . . 0.85 109.15 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 64.8 p -89.26 -31.54 17.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.699 -1.251 . . . . 0.93 110.202 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 262' ' ' SER . . . . . . . . . . . . . 15.7 m -159.06 153.43 24.02 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.168 -0.957 . . . . 0.79 110.071 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 263' ' ' VAL . . . . . . . . . . . . . 51.2 t -122.65 134.51 65.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.615 -0.883 . . . . 0.59 108.615 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 264' ' ' ASN . . . . . 0.471 ' ND2' ' CH2' ' D' ' 182' ' ' TRP . 33.5 t30 -108.51 128.19 54.59 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.543 0.687 . . . . 0.63 110.609 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 265' ' ' VAL . . . . . 0.462 HG21 ' SD ' ' D' ' 314' ' ' MET . 3.2 t -90.76 108.39 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.475 0.655 . . . . 0.59 109.69 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 266' ' ' GLY . . . . . . . . . . . . . . . -80.78 -53.82 3.87 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.184 -1.166 . . . . 0.62 110.184 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 267' ' ' GLY . . . . . . . . . . . . . . . -172.61 152.99 17.82 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 118.715 -1.707 . . . . 0.55 111.462 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 268' ' ' MET . . . . . 0.436 ' HB2' ' H ' ' D' ' 282' ' ' SER . 97.0 mtp -143.12 118.09 10.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.533 -0.981 . . . . 0.71 110.392 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.21 128.2 21.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.421 -0.799 . . . . 0.77 109.489 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 270' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' D' ' 271' ' ' ARG . 16.3 t80 -69.79 161.89 28.95 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.117 -0.99 . . . . 1.2 109.672 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 271' ' ' ARG . . . . . 0.54 ' N ' ' CD1' ' D' ' 270' ' ' PHE . 2.3 mmt180 -160.72 158.56 28.88 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.043 -1.036 . . . . 1.15 109.69 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 272' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -66.46 138.22 57.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.93 -1.107 . . . . 1.39 110.366 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 273' ' ' GLY . . . . . . . . . . . . . . . 95.54 -12.29 67.82 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.721 -1.752 . . . . 1.27 108.721 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 274' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -101.72 163.46 12.25 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.434 -1.039 . . . . 1.19 109.489 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 275' ' ' THR . . . . . 0.564 HG21 HG21 ' D' ' 321' ' ' ILE . 20.8 m -110.01 135.77 50.33 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.686 -0.857 . . . . 1.22 108.686 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 276' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -81.97 119.37 23.88 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.225 -0.922 . . . . 1.25 110.146 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 277' ' ' VAL . . . . . 0.507 HG12 ' CD1' ' D' ' 321' ' ' ILE . 27.4 m -99.18 -28.41 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.433 -0.792 . . . . 1.06 109.622 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 278' ' ' ASN . . . . . 0.468 ' OD1' ' N ' ' D' ' 279' ' ' ASN . 10.4 t-20 -135.85 -177.17 4.57 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.862 0.839 . . . . 1.05 109.659 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 279' ' ' ASN . . . . . 0.468 ' N ' ' OD1' ' D' ' 278' ' ' ASN . 97.7 m-20 -57.03 -29.69 63.59 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.663 -0.648 . . . . 1.23 110.836 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 280' ' ' ALA . . . . . . . . . . . . . . . -148.17 27.07 0.96 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.773 -1.205 . . . . 0.95 109.548 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 281' ' ' VAL . . . . . 0.491 ' O ' HG22 ' D' ' 277' ' ' VAL . 60.5 t -119.05 121.79 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.868 -0.733 . . . . 0.88 109.755 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 282' ' ' SER . . . . . 0.436 ' H ' ' HB2' ' D' ' 268' ' ' MET . 29.1 m -118.52 147.62 43.47 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.436 0.636 . . . . 0.92 110.022 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 283' ' ' VAL . . . . . . . . . . . . . 16.4 m -135.18 142.77 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 122.389 1.09 . . . . 0.96 110.52 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 284' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' D' ' 287' ' ' ASP . 44.1 p-10 -110.73 171.62 7.36 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.971 -1.492 . . . . 0.96 106.971 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 285' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -56.18 -24.03 38.96 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.793 -1.192 . . . . 1.33 109.669 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 286' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -79.73 -43.38 22.73 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.948 -1.095 . . . . 0.96 110.054 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 287' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' D' ' 284' ' ' ASP . 93.1 m-20 -64.2 -42.24 96.72 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.145 -0.972 . . . . 0.8 109.136 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 288' ' ' ILE . . . . . . . . . . . . . 88.9 mt -62.41 -45.88 97.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.247 -0.908 . . . . 1.0 109.462 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 289' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -57.3 -39.43 75.75 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.167 -0.958 . . . . 1.15 110.435 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.58 -40.98 84.83 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.815 -1.178 . . . . 0.8 109.881 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 291' ' ' PHE . . . . . 0.459 ' CE2' ' HG3' ' D' ' 247' ' ' PRO . 40.3 m-85 -63.83 -39.22 93.71 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.375 -0.828 . . . . 0.75 109.666 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 292' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -63.95 -39.39 94.04 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.29 -0.964 . . . . 1.11 110.197 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 293' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -65.97 -41.49 91.13 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.836 -1.165 . . . . 1.07 109.486 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 294' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.21 -43.17 99.44 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.984 -1.072 . . . . 0.8 108.832 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 295' ' ' ASN . . . . . 0.863 ' C ' HD21 ' D' ' 295' ' ' ASN . 0.2 OUTLIER -63.96 -40.13 95.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.117 -0.989 . . . . 0.9 109.881 179.462 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.62 -21.35 65.6 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.837 -1.164 . . . . 1.01 109.256 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 297' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -90.22 9.02 30.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.847 -1.158 . . . . 1.06 109.848 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.28 11.34 82.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.884 -1.286 . . . . 0.93 109.884 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 299' ' ' ILE . . . . . . . . . . . . . 97.7 mt -84.62 134.66 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.938 -1.33 . . . . 0.84 109.107 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 300' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -82.1 141.78 32.85 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.473 -0.891 . . . . 0.95 110.664 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 301' ' ' LEU . . . . . . . . . . . . . 67.1 mt -123.07 111.27 16.36 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.328 -0.619 . . . . 0.74 109.328 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 302' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -115.66 140.09 49.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.395 -0.815 . . . . 0.87 110.162 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 303' ' ' VAL . . . . . 0.615 ' CG2' ' SD ' ' D' ' 314' ' ' MET . 52.6 t -112.02 124.92 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.751 -0.833 . . . . 0.84 108.751 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 304' ' ' ARG . . . . . 0.464 ' HE ' ' CG ' ' D' ' 264' ' ' ASN . 33.4 ptt180 -165.14 137.82 4.45 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.621 -0.832 . . . . 0.88 110.388 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 305' ' ' LYS . . . . . 0.496 ' CD ' ' H ' ' D' ' 305' ' ' LYS . 0.0 OUTLIER -80.97 -45.41 16.69 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.6 -0.84 . . . . 0.97 109.655 179.804 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 306' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.23 153.92 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.117 -0.989 . . . . 1.06 108.785 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 307' ' ' SER . . . . . . . . . . . . . 83.6 p -64.5 -16.37 62.41 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.937 -1.102 . . . . 1.12 109.511 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 308' ' ' THR . . . . . 0.626 HG21 HH12 ' D' ' 181' ' ' ARG . 43.4 p -86.03 -8.97 57.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.06 -1.025 . . . . 1.28 110.116 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 309' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -92.44 152.68 42.43 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.004 -1.06 . . . . 1.2 109.912 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 310' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.27 139.09 80.94 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.915 1.743 . . . . 1.29 111.765 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 311' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -84.15 132.68 34.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.112 -0.992 . . . . 1.08 109.832 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 312' ' ' LEU . . . . . . . . . . . . . 93.2 mt -117.31 154.91 30.42 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 1.13 108.373 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 313' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -91.47 130.59 37.28 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.108 -0.995 . . . . 1.04 109.78 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 314' ' ' MET . . . . . 0.615 ' SD ' ' CG2' ' D' ' 303' ' ' VAL . 8.2 tpt -56.55 -44.11 80.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.592 -0.693 . . . . 0.88 109.63 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 315' ' ' MET . . . . . . . . . . . . . 95.8 mmm -61.1 -40.51 94.01 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.553 -0.717 . . . . 1.02 110.235 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 316' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -61.76 -44.12 97.51 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.341 -0.849 . . . . 1.13 109.758 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 317' ' ' LEU . . . . . . . . . . . . . 92.9 mt -66.47 -41.93 88.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -0.885 . . . . 1.1 109.947 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 318' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.42 -24.32 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 1.13 110.024 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 319' ' ' SER . . . . . 0.477 ' O ' ' C ' ' D' ' 323' ' ' LYS . 0.9 OUTLIER -72.77 -31.56 64.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 1.29 109.594 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 320' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -84.08 -2.56 56.94 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.844 -1.142 . . . . 1.38 109.244 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 321' ' ' ILE . . . . . 0.564 HG21 HG21 ' D' ' 275' ' ' THR . 93.2 mt -113.84 -58.63 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.022 -1.103 . . . . 1.36 108.022 177.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 322' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' D' ' 323' ' ' LYS . 12.1 t0 -94.91 85.04 4.28 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.284 -1.747 . . . . 1.29 106.284 178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 323' ' ' LYS . . . . . 1.272 ' NZ ' ' HA ' ' D' ' 323' ' ' LYS . 0.0 OUTLIER . . . . . 1 C--O 1.524 15.537 0 CA-C-O 126.343 2.973 . . . . 1.54 109.42 -177.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.543 ' HB ' ' HG2' ' A' ' 105' ' ' ARG . 75.0 p . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 121.165 0.507 . . . . 0.87 110.931 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.633 ' O ' ' HD2' ' A' ' 105' ' ' ARG . 47.2 mt -71.53 136.24 26.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.658 -1.978 . . . . 0.78 105.658 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.93 144.72 36.6 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-N 115.246 -0.888 . . . . 0.67 110.557 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.5 mt -126.59 130.91 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.388 -0.968 . . . . 0.55 108.388 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.4 t -125.07 128.82 73.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 105.71 -1.959 . . . . 0.51 105.71 177.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.2 mt -108.69 132.72 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.24 -0.652 . . . . 0.35 109.24 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.81 134.17 6.8 Favored Glycine 0 N--CA 1.47 0.912 0 C-N-CA 120.036 -1.078 . . . . 0.3 111.093 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.687 HG21 ' HB3' ' A' ' 13' ' ' ALA . 14.4 t -142.13 165.72 26.68 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.101 -1.444 . . . . 0.36 107.101 177.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.599 ' ND1' ' OD2' ' A' ' 67' ' ' ASP . 72.9 m80 -68.58 151.95 46.05 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 102.343 -3.206 . . . . 1.57 102.343 174.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.32 -148.14 40.25 Favored Glycine 0 C--N 1.307 -1.03 0 C-N-CA 117.174 -2.441 . . . . 0.43 113.954 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -120.88 26.32 9.15 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.341 1.238 . . . . 0.77 114.341 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.687 ' HB3' HG21 ' A' ' 9' ' ' THR . . . -78.99 -26.93 43.32 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.945 1.461 . . . . 0.28 114.945 -178.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.36 -46.21 76.47 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.051 0.842 . . . . 0.27 112.321 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -60.0 -40.15 88.25 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.583 -0.447 . . . . 0.55 110.892 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -71.36 -34.19 70.24 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.325 0.861 . . . . 0.46 113.325 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.9 mt -65.38 -38.77 91.03 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 106.719 -1.586 . . . . 0.34 106.719 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.1 tp -66.29 -43.84 85.18 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.5 -0.926 . . . . 0.46 108.5 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.694 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 24.3 mttm -60.99 -38.99 87.97 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 120.865 0.364 . . . . 0.57 111.101 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.6 m -64.53 -46.91 80.83 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 108.289 -1.004 . . . . 0.54 108.289 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.83 -44.24 90.86 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 119.898 -0.721 . . . . 0.61 110.755 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.877 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -68.46 -22.7 64.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.416 -0.356 . . . . 2.42 110.42 -178.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.468 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -71.1 -32.31 68.87 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.447 -2.057 . . . . 1.71 105.447 178.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.438 HD21 ' CD2' ' B' ' 10' ' ' HIS . 79.1 mt -84.32 -39.03 19.65 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.459 0.911 . . . . 0.8 113.459 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.487 HD11 HG13 ' A' ' 99' ' ' VAL . 96.1 mt -109.1 -11.9 14.88 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 118.568 2.803 . . . . 0.83 118.568 -175.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.42 165.64 30.93 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 105.21 -3.156 . . . . 0.81 105.21 -175.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -59.96 138.8 57.75 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.59 1.186 . . . . 0.87 112.162 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -105.53 147.12 28.71 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 112.874 -1.966 . . . . 0.72 112.901 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -106.15 158.46 16.82 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 113.949 -1.478 . . . . 0.95 107.537 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.7 t30 57.42 42.07 25.27 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.73 -1.123 . . . . 0.74 113.951 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.7 t -131.12 135.01 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.053 -1.092 . . . . 0.61 108.053 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.86 168.14 19.11 Favored Glycine 0 N--CA 1.476 1.307 0 N-CA-C 109.428 -1.469 . . . . 0.51 109.428 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -156.15 158.64 38.0 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 121.75 -0.853 . . . . 0.52 108.699 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 pt -137.68 160.03 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 115.416 -0.811 . . . . 0.51 109.454 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -115.06 163.41 15.65 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 108.533 -0.914 . . . . 0.58 108.533 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.429 ' CD1' ' C ' ' A' ' 36' ' ' PHE . 1.6 t80 -134.87 116.86 15.24 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 106.627 -1.619 . . . . 0.65 106.627 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.9 t -107.78 145.59 31.66 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 113.845 -1.525 . . . . 0.74 110.581 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -56.6 134.92 67.43 Favored 'Trans proline' 0 C--N 1.345 0.378 0 N-CA-C 108.292 -1.465 . . . . 0.84 108.292 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.46 -25.42 15.46 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.406 -1.478 . . . . 0.93 109.406 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -84.64 158.35 20.88 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.597 0.713 . . . . 0.84 109.611 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 50.8 p30 -125.89 179.47 5.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.937 -1.135 . . . . 2.42 107.937 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.84 -34.69 73.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.495 0.554 . . . . 0.8 112.495 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -65.48 -36.17 83.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.281 0.562 . . . . 2.93 111.681 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.4 m -63.66 -47.64 80.45 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.993 -1.855 . . . . 0.87 105.993 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.1 mt -63.59 -36.37 83.58 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.186 -0.605 . . . . 0.73 112.433 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.7 mt -59.9 -42.76 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.971 -1.122 . . . . 0.81 107.971 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -62.83 -42.55 99.78 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 120.014 -0.675 . . . . 0.93 110.381 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -62.45 -42.99 99.86 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 119.342 -0.943 . . . . 0.73 110.839 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -62.63 -45.4 93.0 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 108.677 -0.86 . . . . 0.66 108.677 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -60.71 -39.78 89.82 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.46 0.541 . . . . 0.83 112.46 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.02 -34.82 79.34 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.344 -0.542 . . . . 0.79 109.829 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -71.06 -43.72 67.23 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 119.594 -0.842 . . . . 0.69 109.451 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.1 mt -60.0 -37.7 80.48 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 116.511 -0.313 . . . . 0.77 111.587 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.74 -25.8 29.98 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.222 0.453 . . . . 0.88 112.222 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -96.25 -4.68 41.9 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.04 -0.527 . . . . 0.81 112.394 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -105.61 158.64 16.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.714 0.635 . . . . 0.81 112.714 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -90.47 107.43 19.15 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 102.39 -3.189 . . . . 0.92 102.39 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.9 p -106.41 14.99 26.59 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 124.203 0.94 . . . . 0.83 110.842 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.3 p -63.71 -33.86 76.57 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 115.172 1.545 . . . . 0.97 115.172 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -92.81 -8.84 42.46 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 123.335 0.397 . . . . 1.02 111.463 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.67 172.03 12.98 Favored Glycine 0 C--N 1.314 -0.641 0 C-N-CA 119.351 -1.404 . . . . 0.8 112.892 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.1 t -139.04 130.86 36.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.004 0 N-CA-C 109.11 -0.7 . . . . 0.68 109.11 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 29.6 tp -116.57 114.99 24.9 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 125.323 1.64 . . . . 0.56 107.524 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -92.6 122.41 34.99 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 105.642 -1.984 . . . . 0.57 105.642 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.8 mt -109.72 114.99 29.03 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 104.644 -2.354 . . . . 0.4 104.644 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.06 163.71 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-O 121.706 0.765 . . . . 0.38 112.821 -176.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.599 ' OD2' ' ND1' ' A' ' 10' ' ' HIS . 12.1 p-10 -65.51 -54.66 24.98 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 117.117 2.266 . . . . 0.33 117.117 -176.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 67.3 p -141.48 151.49 43.38 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 122.633 1.206 . . . . 0.45 112.652 -176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -65.86 134.36 52.87 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.791 -1.55 . . . . 0.72 108.013 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.85 -7.12 75.82 Favored Glycine 0 N--CA 1.468 0.781 0 N-CA-C 120.092 2.797 . . . . 0.67 120.092 176.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.36 174.83 55.0 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 119.686 1.743 . . . . 0.58 109.313 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.51 ' HB2' ' HD3' ' A' ' 73' ' ' PRO . 33.3 m -57.64 -47.22 99.34 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 122.185 -0.597 . . . . 1.42 111.734 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 72' ' ' SER . 85.2 Cg_exo -53.75 -41.76 71.7 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 N-CA-C 110.351 -0.673 . . . . 0.51 110.351 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -67.42 -48.67 66.64 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.531 0.519 . . . . 0.65 109.645 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.96 -42.47 94.14 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.648 0.981 . . . . 2.13 113.648 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.97 -42.9 84.36 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.366 -0.933 . . . . 0.67 111.232 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.97 -38.19 90.14 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.531 -0.914 . . . . 0.63 108.531 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.815 ' O ' HG13 ' A' ' 82' ' ' VAL . 4.0 m -59.33 -38.69 80.95 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.16 0.43 . . . . 1.52 112.16 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.452 HH11 ' HD3' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -68.78 -29.25 67.59 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.548 -0.461 . . . . 3.43 112.022 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.409 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 73.0 mt -77.25 -43.1 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 111.91 0.337 . . . . 0.78 111.91 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 87' ' ' TYR . 2.5 m -78.89 -17.52 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 115.441 1.645 . . . . 0.8 115.441 -175.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.815 HG13 ' O ' ' A' ' 78' ' ' SER . 30.5 m -29.09 -55.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 121.397 3.851 . . . . 0.94 121.397 -176.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.527 ' OD1' HG23 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -126.09 38.96 4.04 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 116.701 -2.0 . . . . 1.03 108.947 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -112.48 133.74 54.39 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.613 -1.176 . . . . 0.88 109.479 -179.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -78.65 141.6 37.85 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 106.674 -1.602 . . . . 1.03 106.674 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 61.1 m170 62.43 35.33 14.9 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 114.386 1.254 . . . . 0.95 114.386 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.488 ' HB3' ' HB ' ' A' ' 81' ' ' VAL . 6.2 m-85 -128.63 129.88 46.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 105.25 -2.13 . . . . 0.77 105.25 175.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -145.49 156.26 43.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.173 -0.611 . . . . 0.7 110.226 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.3 t -122.67 128.76 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 N-CA-C 105.623 -1.991 . . . . 0.57 105.623 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.1 mt -124.73 120.77 59.67 Favored 'Isoleucine or valine' 0 C--O 1.253 1.265 0 N-CA-C 107.496 -1.298 . . . . 0.54 107.496 177.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.33 164.16 17.25 Favored 'General case' 0 CA--C 1.571 1.772 0 CA-C-N 114.571 -1.195 . . . . 0.45 111.095 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.19 24.45 57.24 Favored Glycine 0 C--O 1.222 -0.639 0 CA-C-N 115.684 -0.689 . . . . 0.36 114.512 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.8 p -48.64 132.88 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 112.91 0.707 . . . . 0.28 112.91 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' B' ' 94' ' ' ASN . 52.4 p30 -142.11 170.24 16.09 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.512 -1.292 . . . . 0.44 107.512 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 44.8 mm -61.64 -42.68 85.03 Favored Pre-proline 0 C--O 1.243 0.734 0 N-CA-C 113.771 1.026 . . . . 0.47 113.771 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.415 ' HD2' ' CG ' ' A' ' 94' ' ' ASN . 24.9 Cg_exo -57.06 -43.82 50.11 Favored 'Trans proline' 0 CA--C 1.552 1.403 0 CA-C-N 119.732 0.94 . . . . 0.56 110.113 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 40.4 ttm -61.4 -48.88 79.19 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 120.177 -0.609 . . . . 0.51 109.642 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.6 tp -61.18 -47.52 85.78 Favored 'General case' 0 C--O 1.203 -1.349 0 C-N-CA 120.344 -0.543 . . . . 0.52 112.118 -177.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.487 HG13 HD11 ' A' ' 25' ' ' LEU . 85.9 t -62.37 -49.25 84.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 112.36 0.504 . . . . 0.66 112.36 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.76 ' CA ' ' OE1' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -63.93 -40.9 97.53 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.256 -0.577 . . . . 2.05 111.213 -179.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 53.5 m -65.94 -45.7 80.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.825 -0.625 . . . . 0.67 110.89 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.6 mt -65.25 -37.49 87.4 Favored 'General case' 0 CA--C 1.551 1.0 0 O-C-N 123.518 0.511 . . . . 0.74 110.018 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.489 ' HE3' ' HB3' ' A' ' 103' ' ' MET . 3.0 mtp -66.32 -45.92 78.62 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.429 -0.794 . . . . 1.08 111.699 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.401 ' O ' ' HD3' ' A' ' 109' ' ' PRO . . . -67.72 -33.69 75.38 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.897 0.703 . . . . 0.88 112.897 -177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.633 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 17.6 ttp180 -53.03 -32.9 49.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.873 -0.603 . . . . 0.86 112.599 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -73.19 -19.8 61.03 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 113.598 0.962 . . . . 2.35 113.598 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -90.61 18.23 6.59 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 121.906 0.86 . . . . 2.28 109.302 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.9 t70 46.82 59.2 16.48 Favored Pre-proline 0 C--N 1.313 -1.009 0 N-CA-C 116.174 1.916 . . . . 1.06 116.174 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.405 ' HG3' HD13 ' A' ' 114' ' ' LEU . 46.9 Cg_endo -73.8 168.92 23.59 Favored 'Trans proline' 0 C--O 1.207 -1.048 0 C-N-CA 120.966 1.111 . . . . 0.95 110.432 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.7 p -78.05 163.12 26.19 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 106.245 -1.761 . . . . 0.99 106.245 175.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -56.66 -51.32 69.17 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-O 119.105 -0.474 . . . . 0.88 111.83 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -59.15 -36.29 75.01 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.784 0.72 . . . . 0.97 112.607 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -64.74 -45.81 84.9 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.4 -0.593 . . . . 1.07 109.4 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.405 HD13 ' HG3' ' A' ' 109' ' ' PRO . 15.6 tp -65.33 -45.07 85.73 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 120.757 -0.377 . . . . 0.8 110.728 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.78 -47.8 85.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.335 -0.546 . . . . 0.71 109.962 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.67 -43.23 97.92 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 120.878 0.371 . . . . 0.85 111.944 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.9 tp -63.76 -42.31 97.83 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 119.495 -0.288 . . . . 0.83 110.376 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.78 -44.39 96.85 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.831 -0.748 . . . . 0.66 111.861 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.43 -46.32 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 109.295 -0.632 . . . . 0.68 109.295 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -63.58 -45.58 89.78 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 113.06 0.763 . . . . 0.93 113.06 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 57.6 p -71.79 -31.5 66.66 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 120.335 -0.546 . . . . 0.74 111.701 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.12 -45.83 94.58 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 108.795 -1.722 . . . . 0.59 108.795 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.5 mtp-105 -72.63 -41.7 65.22 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.228 0.455 . . . . 0.82 112.228 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -70.65 -19.86 62.77 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.536 -0.866 . . . . 2.54 111.502 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.42 -16.33 77.36 Favored Glycine 0 CA--C 1.535 1.29 0 O-C-N 124.041 0.838 . . . . 0.67 112.826 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.0 t -89.73 111.59 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 106.452 -1.684 . . . . 0.74 106.452 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -154.66 138.1 15.88 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.835 -0.802 . . . . 2.84 108.835 -173.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.33 147.53 23.4 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.044 0.926 . . . . 0.92 109.494 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 130' ' ' LYS . 41.8 tp -67.81 -57.94 5.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.071 -0.968 . . . . 1.03 110.7 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 129' ' ' LEU . 76.0 mttt . . . . . 1 C--O 1.433 10.715 1 CA-C-O 145.741 12.21 . . . . 2.77 110.634 177.727 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' THR . . . . . 0.526 ' HB ' ' HG2' ' B' ' 105' ' ' ARG . 76.1 p . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.185 0.517 . . . . 0.95 110.955 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ILE . . . . . 0.623 ' O ' ' HD2' ' B' ' 105' ' ' ARG . 47.1 mt -71.46 136.28 26.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 105.676 -1.972 . . . . 0.91 105.676 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.1 144.7 36.27 Favored 'General case' 0 C--O 1.209 -1.078 0 CA-C-N 115.319 -0.855 . . . . 0.81 110.52 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 40.8 mt -126.53 130.91 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 108.436 -0.95 . . . . 0.68 108.436 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 92.3 t -125.08 128.81 73.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 105.711 -1.959 . . . . 0.68 105.711 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . . . . . . . . . 38.2 mt -108.66 132.72 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.27 -0.641 . . . . 0.52 109.27 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.67 133.94 6.69 Favored Glycine 0 N--CA 1.472 1.084 0 C-N-CA 120.086 -1.054 . . . . 0.51 110.846 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.742 HG21 ' HB3' ' B' ' 13' ' ' ALA . 14.9 t -146.0 162.07 38.68 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.209 -1.404 . . . . 0.53 107.209 -178.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . 0.438 ' CD2' HD21 ' A' ' 24' ' ' LEU . 3.0 m80 -68.62 144.03 54.63 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 102.948 -2.982 . . . . 1.33 102.948 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.83 -141.96 26.01 Favored Glycine 0 C--N 1.306 -1.108 0 C-N-CA 117.237 -2.411 . . . . 0.56 114.109 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -123.5 26.16 7.94 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 113.945 1.091 . . . . 0.85 113.945 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.742 ' HB3' HG21 ' B' ' 9' ' ' THR . . . -79.16 -26.77 42.71 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.898 1.444 . . . . 0.38 114.898 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.36 -46.18 76.48 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.154 0.888 . . . . 0.4 112.379 -176.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -59.98 -40.16 88.15 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.485 -0.486 . . . . 0.56 110.928 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.31 -34.27 70.45 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.34 0.867 . . . . 0.45 113.34 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 85.4 mt -65.34 -38.79 91.2 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 106.706 -1.59 . . . . 0.31 106.706 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' LEU . . . . . . . . . . . . . 18.9 tp -66.27 -43.81 85.41 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.537 -0.912 . . . . 0.5 108.537 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -61.02 -39.01 88.13 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.923 0.392 . . . . 0.55 111.092 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 16.7 m -64.49 -46.9 81.01 Favored 'General case' 0 C--O 1.248 1.026 0 N-CA-C 108.268 -1.012 . . . . 0.43 108.268 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.83 -44.21 90.87 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 119.875 -0.73 . . . . 0.52 110.841 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 1.293 ' OE2' ' HG2' ' B' ' 27' ' ' GLU . 15.0 tt0 -68.52 -22.63 64.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.345 -0.388 . . . . 2.39 110.478 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -32.27 68.69 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 105.448 -2.056 . . . . 1.71 105.448 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 81.1 mt -84.15 -39.07 19.87 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.522 0.934 . . . . 0.68 113.522 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.488 HD11 HG13 ' B' ' 99' ' ' VAL . 95.4 mt -109.12 -11.82 14.89 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 118.636 2.828 . . . . 0.75 118.636 -175.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' B' ' 22' ' ' GLU . . . 98.37 165.67 31.0 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 105.247 -3.141 . . . . 0.74 105.247 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . 1.293 ' HG2' ' OE2' ' B' ' 22' ' ' GLU . 40.4 mt-10 -59.88 138.84 57.71 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 122.609 1.195 . . . . 0.82 112.217 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -105.62 147.06 28.87 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 112.913 -1.949 . . . . 0.71 112.918 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -106.22 158.44 16.84 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.952 -1.476 . . . . 0.95 107.47 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ASN . . . . . . . . . . . . . 29.9 t30 57.43 42.07 25.24 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.64 -1.164 . . . . 0.84 113.9 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 94.1 t -131.02 135.03 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 108.115 -1.069 . . . . 0.68 108.115 176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.85 168.19 19.07 Favored Glycine 0 N--CA 1.477 1.38 0 N-CA-C 109.404 -1.478 . . . . 0.61 109.404 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -156.12 158.61 37.99 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.783 -0.821 . . . . 0.61 108.783 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 pt -137.67 160.0 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 O-C-N 124.002 0.814 . . . . 0.67 109.403 178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -114.98 163.41 15.62 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 108.493 -0.929 . . . . 0.68 108.493 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' PHE . . . . . 0.41 ' CD1' ' C ' ' B' ' 36' ' ' PHE . 1.6 t80 -134.91 116.91 15.27 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.605 -1.628 . . . . 0.82 106.605 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 95.9 t -107.83 145.55 31.6 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 113.876 -1.511 . . . . 0.85 110.601 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -56.6 134.98 67.83 Favored 'Trans proline' 0 C--N 1.346 0.446 0 N-CA-C 108.302 -1.461 . . . . 0.95 108.302 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.41 -25.3 15.83 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 109.415 -1.474 . . . . 1.06 109.415 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -84.61 158.31 20.92 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.583 0.706 . . . . 0.97 109.592 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -125.86 179.44 5.19 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.952 -1.129 . . . . 2.47 107.952 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.92 -34.57 73.4 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.538 0.57 . . . . 1.0 112.538 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.43 -36.3 83.51 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.261 0.553 . . . . 3.02 111.66 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' THR . . . . . . . . . . . . . 88.4 m -63.6 -47.58 80.84 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 106.033 -1.84 . . . . 1.02 106.033 176.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 35.0 mt -63.62 -36.48 83.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.213 -0.595 . . . . 0.9 112.344 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.86 -42.75 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 107.948 -1.131 . . . . 1.04 107.948 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -62.89 -42.56 99.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 120.046 -0.662 . . . . 1.09 110.304 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -62.35 -43.09 99.65 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 119.348 -0.941 . . . . 0.88 110.906 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -62.49 -45.43 93.05 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 108.719 -0.845 . . . . 0.83 108.719 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -60.73 -39.82 90.06 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.383 0.512 . . . . 1.02 112.383 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.05 -34.82 79.33 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.34 -0.544 . . . . 0.9 109.802 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -70.99 -43.79 67.28 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 119.589 -0.844 . . . . 0.82 109.437 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.97 -37.7 80.4 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.52 -0.309 . . . . 0.9 111.582 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.72 -25.77 29.6 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 112.257 0.466 . . . . 0.98 112.257 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -96.27 -4.63 41.92 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 112.397 0.517 . . . . 0.91 112.397 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 74.6 mt -105.6 158.5 16.65 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.748 0.648 . . . . 0.94 112.748 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -90.36 107.42 19.14 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 102.382 -3.192 . . . . 1.02 102.382 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' THR . . . . . . . . . . . . . 73.4 p -106.53 15.07 26.32 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 124.267 0.979 . . . . 1.01 110.826 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 72.1 p -63.6 -33.94 76.72 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 115.249 1.574 . . . . 1.12 115.249 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -92.82 -8.87 42.33 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.394 0.434 . . . . 1.14 111.41 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.71 172.04 12.98 Favored Glycine 0 C--N 1.314 -0.683 0 C-N-CA 119.341 -1.409 . . . . 0.98 112.882 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 58.6 t -138.95 130.82 36.42 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 109.17 -0.678 . . . . 0.88 109.17 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . . . . . . . . . 29.6 tp -116.48 115.0 24.98 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 125.325 1.64 . . . . 0.76 107.508 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -92.57 122.34 34.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 105.637 -1.986 . . . . 0.8 105.637 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 83.0 mt -109.66 114.98 29.04 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 104.636 -2.357 . . . . 0.57 104.636 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.07 163.86 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 121.67 0.748 . . . . 0.61 112.752 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' B' ' 67' ' ' ASP . 12.5 p-10 -65.62 -54.55 26.22 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 117.193 2.294 . . . . 0.53 117.193 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' THR . . . . . . . . . . . . . 74.5 p -141.57 151.48 43.23 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 122.57 1.176 . . . . 0.67 112.7 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -65.98 134.4 52.86 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 113.77 -1.559 . . . . 0.97 107.959 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.79 -7.04 75.89 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 120.137 2.815 . . . . 0.89 120.137 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.4 174.84 54.99 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-N 119.607 1.704 . . . . 0.81 109.356 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.496 ' HB2' ' HD3' ' B' ' 73' ' ' PRO . 20.4 m -57.58 -47.23 99.33 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 122.131 -0.629 . . . . 1.52 111.755 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' B' ' 72' ' ' SER . 85.7 Cg_exo -53.74 -41.81 71.26 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 N-CA-C 110.327 -0.682 . . . . 0.73 110.327 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -67.4 -48.66 66.72 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.531 0.52 . . . . 0.9 109.605 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -60.0 -42.48 94.35 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.689 0.996 . . . . 2.24 113.689 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.91 84.97 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.322 -0.951 . . . . 0.91 111.401 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.95 -38.18 90.04 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.553 -0.906 . . . . 0.89 108.553 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.801 ' O ' HG13 ' B' ' 82' ' ' VAL . 3.4 m -59.28 -38.84 81.13 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.121 0.415 . . . . 1.62 112.121 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.532 ' O ' HG22 ' B' ' 82' ' ' VAL . 3.6 mtt180 -68.61 -29.33 67.82 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.617 -0.433 . . . . 3.5 112.106 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ILE . . . . . . . . . . . . . 72.8 mt -77.24 -42.98 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 111.943 0.349 . . . . 1.04 111.943 178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' B' ' 87' ' ' TYR . 2.5 m -78.93 -17.6 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 115.438 1.644 . . . . 1.07 115.438 -175.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . 0.801 HG13 ' O ' ' B' ' 78' ' ' SER . 10.5 m -29.11 -55.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 121.398 3.851 . . . . 1.2 121.398 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.04 38.97 4.04 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 116.708 -1.997 . . . . 1.32 109.057 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.48 133.71 54.4 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.62 -1.173 . . . . 1.16 109.514 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -78.68 141.59 37.82 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.666 -1.605 . . . . 1.29 106.666 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' HIS . . . . . . . . . . . . . 61.0 m170 62.45 35.23 14.89 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 114.435 1.272 . . . . 1.16 114.435 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' TYR . . . . . 0.492 ' HB3' ' HB ' ' B' ' 81' ' ' VAL . 6.2 m-85 -128.46 129.95 46.85 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.257 -2.127 . . . . 0.99 105.257 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -145.61 156.18 43.51 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.181 -0.608 . . . . 0.93 110.293 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 19.1 t -122.6 128.7 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 N-CA-C 105.638 -1.986 . . . . 0.82 105.638 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 34.2 mt -124.7 120.75 59.65 Favored 'Isoleucine or valine' 0 C--O 1.251 1.167 0 N-CA-C 107.536 -1.283 . . . . 0.71 107.536 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.35 164.08 17.28 Favored 'General case' 0 CA--C 1.571 1.759 0 CA-C-N 114.616 -1.175 . . . . 0.65 111.087 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.37 24.31 57.02 Favored Glycine 0 CA--C 1.502 -0.772 0 CA-C-N 115.608 -0.724 . . . . 0.53 114.569 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 11.9 p -48.67 132.98 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 N-CA-C 112.903 0.705 . . . . 0.43 112.903 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' ASN . . . . . 0.599 ' HB3' ' HB3' ' A' ' 94' ' ' ASN . 52.6 p30 -142.22 170.14 16.28 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.503 -1.295 . . . . 0.4 107.503 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.418 ' HA ' HD13 ' B' ' 95' ' ' ILE . 46.8 mm -61.65 -42.56 84.38 Favored Pre-proline 0 C--O 1.243 0.72 0 N-CA-C 113.833 1.049 . . . . 0.39 113.833 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' B' ' 94' ' ' ASN . 24.7 Cg_exo -57.12 -43.79 50.0 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 CA-C-N 119.726 0.938 . . . . 0.51 110.091 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' MET . . . . . . . . . . . . . 40.4 ttm -61.42 -48.84 79.34 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 120.289 -0.564 . . . . 0.52 109.596 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 14.6 tp -61.21 -47.58 85.47 Favored 'General case' 0 C--O 1.205 -1.286 0 C-N-CA 120.371 -0.532 . . . . 0.51 112.095 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . 0.488 HG13 HD11 ' B' ' 25' ' ' LEU . 93.7 t -62.36 -49.24 84.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 112.385 0.513 . . . . 0.61 112.385 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.592 ' HA ' ' OE1' ' B' ' 100' ' ' GLU . 0.1 OUTLIER -63.91 -40.91 97.57 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.216 -0.594 . . . . 2.06 111.159 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' THR . . . . . . . . . . . . . 54.0 m -66.06 -45.65 80.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.87 -0.605 . . . . 0.7 110.852 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 97.5 mt -65.15 -37.5 87.61 Favored 'General case' 0 CA--C 1.551 0.991 0 O-C-N 123.563 0.539 . . . . 0.74 110.014 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' MET . . . . . . . . . . . . . 2.3 mtm -66.34 -45.91 78.63 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 121.369 -0.832 . . . . 1.05 111.766 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.418 ' O ' ' HD3' ' B' ' 109' ' ' PRO . . . -67.81 -33.64 75.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.904 0.705 . . . . 0.9 112.904 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.623 ' HD2' ' O ' ' B' ' 3' ' ' ILE . 13.0 ttp180 -53.04 -32.86 49.08 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.86 -0.609 . . . . 0.91 112.632 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -73.21 -19.77 61.01 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 113.728 1.011 . . . . 2.35 113.728 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -90.54 18.19 6.56 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.805 0.812 . . . . 2.29 109.271 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 13.9 t70 46.86 59.12 16.62 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 116.232 1.938 . . . . 1.15 116.232 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' B' ' 104' ' ' ALA . 47.3 Cg_endo -73.79 168.86 23.74 Favored 'Trans proline' 0 C--O 1.207 -1.06 0 C-N-CA 120.981 1.121 . . . . 1.04 110.427 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' SER . . . . . . . . . . . . . 54.5 p -77.87 163.17 26.29 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 106.351 -1.722 . . . . 1.13 106.351 175.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -56.78 -51.18 69.94 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 119.059 -0.496 . . . . 1.04 111.855 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -59.31 -36.28 75.34 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 118.817 0.735 . . . . 1.17 112.5 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -64.71 -45.84 84.83 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.331 -0.618 . . . . 1.17 109.331 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.414 HD13 ' HG3' ' B' ' 109' ' ' PRO . 15.6 tp -65.43 -44.91 85.87 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 120.711 -0.396 . . . . 0.92 110.763 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.79 -47.81 85.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.382 -0.527 . . . . 0.88 109.994 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.26 97.84 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 111.958 0.355 . . . . 0.96 111.958 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 55.0 tp -63.74 -42.28 97.9 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 119.444 -0.312 . . . . 0.85 110.363 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.7 -44.49 96.5 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.876 -0.729 . . . . 0.73 111.875 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.43 -46.27 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.313 -0.625 . . . . 0.79 109.313 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -63.58 -45.54 89.96 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.137 0.792 . . . . 0.95 113.137 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 57.5 p -71.75 -31.53 66.76 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 120.38 -0.528 . . . . 0.7 111.774 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.12 -45.78 94.7 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 108.86 -1.696 . . . . 0.59 108.86 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' ARG . . . . . . . . . . . . . 9.2 mtp-105 -72.65 -41.72 65.16 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 112.213 0.449 . . . . 0.86 112.213 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -70.59 -19.82 62.82 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.468 -0.893 . . . . 2.5 111.576 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . . . . . . . . . . . -72.52 -16.31 77.55 Favored Glycine 0 CA--C 1.534 1.223 0 O-C-N 124.105 0.878 . . . . 0.59 112.829 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 94.3 t -89.66 111.63 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 106.453 -1.684 . . . . 0.62 106.453 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -154.69 138.02 15.79 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.861 -0.792 . . . . 2.73 108.861 -173.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.31 147.53 23.39 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 122.036 0.922 . . . . 0.69 109.482 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' B' ' 130' ' ' LYS . 41.9 tp -67.9 -58.12 5.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.114 -0.948 . . . . 0.78 110.653 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' B' ' 129' ' ' LEU . 76.5 mttt . . . . . 1 C--O 1.433 10.713 1 CA-C-O 145.661 12.172 . . . . 2.73 110.616 177.829 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' D' D ' 159' ' ' ASN . . . . . 0.701 ' ND2' ' NZ ' ' D' ' 259' ' ' LYS . 1.8 t-20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 108.988 -0.745 . . . . 1.37 108.988 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 160' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -85.89 25.54 1.1 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.449 -0.945 . . . . 1.65 108.449 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 161' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -118.62 -141.9 0.36 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.619 -0.882 . . . . 1.61 108.619 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 162' ' ' MET . . . . . 0.584 ' SD ' HG21 ' D' ' 240' ' ' VAL . 0.3 OUTLIER -61.75 156.13 21.1 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.895 -1.128 . . . . 1.25 110.492 -178.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 163' ' ' VAL . . . . . . . . . . . . . 93.2 t -113.04 117.76 56.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 109.142 -0.688 . . . . 1.23 109.142 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 164' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.66 103.33 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.56 -0.904 . . . . 0.96 108.56 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.65 -35.2 80.1 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.121 -1.592 . . . . 0.89 109.121 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 tp -172.13 147.94 2.13 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.86 -1.136 . . . . 0.76 111.27 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 167' ' ' ALA . . . . . . . . . . . . . . . -117.68 104.14 10.71 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.167 -0.679 . . . . 0.58 109.167 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 168' ' ' ARG . . . . . 0.868 ' NH1' HG12 ' D' ' 178' ' ' VAL . 44.4 ttp180 -106.2 126.01 51.69 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.923 0.868 . . . . 0.57 110.983 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 169' ' ' ILE . . . . . . . . . . . . . 82.1 mt -95.55 129.27 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 109.183 -0.673 . . . . 0.37 109.183 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 170' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -165.88 117.07 1.05 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.417 -0.802 . . . . 0.43 110.349 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 171' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -62.89 -10.07 12.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.564 -0.71 . . . . 0.5 109.794 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 172' ' ' ARG . . . . . 0.68 ' NH2' ' CE1' ' D' ' 175' ' ' HIS . 88.0 mtm180 -101.7 -3.9 27.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.905 -1.122 . . . . 0.7 110.418 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 173' ' ' LEU . . . . . 0.771 HD12 ' N ' ' D' ' 173' ' ' LEU . 6.8 mp 56.06 -99.77 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 120.101 -0.64 . . . . 0.39 109.372 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 174' ' ' ILE . . . . . . . . . . . . . 96.5 mt -105.66 113.58 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.017 -1.052 . . . . 0.59 109.32 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 175' ' ' HIS . . . . . 0.68 ' CE1' ' NH2' ' D' ' 172' ' ' ARG . 10.4 p80 -142.01 120.7 12.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.251 -0.905 . . . . 0.7 108.648 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 176' ' ' GLY . . . . . . . . . . . . . . . 79.95 -141.18 23.12 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 110.027 -1.229 . . . . 0.84 110.027 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 177' ' ' GLN . . . . . 0.456 ' O ' ' C ' ' D' ' 178' ' ' VAL . 4.7 pt20 -113.04 4.76 16.84 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.427 -0.953 . . . . 1.19 108.427 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 178' ' ' VAL . . . . . 0.868 HG12 ' NH1' ' D' ' 168' ' ' ARG . 38.1 t -48.22 -42.61 11.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 117.499 -1.68 . . . . 0.82 108.597 171.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 179' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' D' ' 183' ' ' THR . . . -73.24 -36.34 66.42 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.002 -1.061 . . . . 0.81 110.142 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 180' ' ' THR . . . . . . . . . . . . . 21.7 m -66.28 -54.73 21.43 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.77 -0.772 . . . . 1.06 109.671 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 181' ' ' ARG . . . . . 0.626 HH12 HG21 ' D' ' 308' ' ' THR . 73.6 ttt180 -64.59 -43.73 92.9 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.624 -0.672 . . . . 1.3 110.583 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 182' ' ' TRP . . . . . 0.544 ' O ' HG23 ' D' ' 186' ' ' THR . 19.6 m95 -65.85 -32.04 73.34 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.131 -0.981 . . . . 0.9 109.589 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 183' ' ' THR . . . . . 0.834 HG21 HG21 ' D' ' 216' ' ' VAL . 69.3 m -65.4 -46.99 77.86 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.926 -1.108 . . . . 1.04 110.166 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 184' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -69.93 -42.77 72.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.148 -0.97 . . . . 1.41 110.656 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 185' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -68.41 -39.53 81.59 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.806 -1.184 . . . . 1.29 109.615 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 186' ' ' THR . . . . . 0.544 HG23 ' O ' ' D' ' 182' ' ' TRP . 72.9 p -81.32 -1.39 45.09 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.2 -0.937 . . . . 1.05 109.682 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 187' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 52.18 48.4 22.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.087 -1.008 . . . . 1.37 108.637 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 188' ' ' VAL . . . . . . . . . . . . . 47.8 t -104.97 133.54 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.146 -0.971 . . . . 1.05 110.027 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 189' ' ' SER . . . . . . . . . . . . . 27.4 p -109.78 -6.44 15.27 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.804 -0.813 . . . . 1.19 108.804 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 190' ' ' ARG . . . . . . . . . . . . . 29.3 mtt-85 -135.84 142.92 44.87 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.484 0.659 . . . . 1.3 110.41 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 191' ' ' ILE . . . . . . . . . . . . . 87.5 mt -133.3 127.46 54.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.243 -1.021 . . . . 0.8 108.243 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 192' ' ' ILE . . . . . 0.454 HD12 HG11 ' D' ' 240' ' ' VAL . 97.1 mt -115.48 128.86 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.205 -0.934 . . . . 0.85 109.734 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 193' ' ' VAL . . . . . . . . . . . . . 53.8 t -99.86 129.1 51.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.711 -0.848 . . . . 0.57 108.711 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 194' ' ' VAL . . . . . . . . . . . . . 42.5 t -112.75 103.75 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.487 -0.758 . . . . 0.61 109.334 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 195' ' ' SER . . . . . . . . . . . . . 37.5 t -167.36 125.69 1.29 Allowed 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.301 -0.96 . . . . 0.61 109.276 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 196' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -73.23 -34.76 66.07 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.512 -0.742 . . . . 0.87 109.791 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 197' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -65.66 -45.37 83.21 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.021 -1.049 . . . . 0.73 109.991 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 198' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.26 -43.0 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.16 -0.962 . . . . 0.62 109.062 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.63 -26.53 56.14 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.681 -0.807 . . . . 0.8 109.151 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 200' ' ' ALA . . . . . . . . . . . . . . . -84.9 -5.34 59.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.986 -1.071 . . . . 0.84 109.905 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 201' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -102.87 95.38 6.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.901 -1.124 . . . . 0.72 109.546 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 202' ' ' THR . . . . . . . . . . . . . 61.2 p -66.11 -33.17 75.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -0.888 . . . . 1.48 110.583 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 203' ' ' VAL . . . . . . . . . . . . . 65.6 t -66.54 -47.35 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.769 -1.207 . . . . 0.81 109.472 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 204' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -63.87 -42.16 97.59 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.348 -0.941 . . . . 0.63 109.453 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 205' ' ' LYS . . . . . 0.51 ' O ' HG23 ' D' ' 209' ' ' THR . 86.6 tttt -58.11 -42.36 85.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.092 -1.005 . . . . 0.89 109.338 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 206' ' ' THR . . . . . . . . . . . . . 99.2 m -60.63 -48.82 80.08 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.098 -1.041 . . . . 0.82 109.528 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 207' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.7 -44.25 96.72 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.92 -1.113 . . . . 0.77 110.81 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 208' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' D' ' 208' ' ' LEU . 82.1 mt -62.6 -41.5 99.01 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.693 -1.254 . . . . 0.67 110.145 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 209' ' ' THR . . . . . 0.51 HG23 ' O ' ' D' ' 205' ' ' LYS . 73.6 p -67.72 -31.86 72.09 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.429 -0.794 . . . . 0.85 110.31 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 210' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -80.42 -17.61 51.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.787 -1.196 . . . . 2.5 110.808 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 211' ' ' VAL . . . . . . . . . . . . . 17.6 m -107.61 17.52 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.09 -1.006 . . . . 0.82 108.77 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 212' ' ' ALA . . . . . . . . . . . . . . . -64.04 123.42 82.03 Favored Pre-proline 0 N--CA 1.482 1.134 0 N-CA-C 107.868 -1.16 . . . . 0.95 107.868 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 213' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -44.29 144.51 2.9 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 122.11 1.873 . . . . 1.03 112.688 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 214' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.46 134.85 66.95 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.161 1.907 . . . . 1.24 112.146 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . 79.82 -8.58 49.19 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.024 -1.231 . . . . 1.25 110.024 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 216' ' ' VAL . . . . . 0.834 HG21 HG21 ' D' ' 183' ' ' THR . 56.0 t -114.66 136.82 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -1.105 . . . . 1.1 108.94 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 217' ' ' THR . . . . . . . . . . . . . 6.8 p -104.84 135.74 45.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.431 -0.793 . . . . 1.1 109.921 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 218' ' ' ALA . . . . . . . . . . . . . . . -110.11 131.28 55.2 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.175 -1.046 . . . . 0.83 108.175 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 219' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -120.95 153.51 37.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.457 -0.777 . . . . 1.01 109.734 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 220' ' ' VAL . . . . . . . . . . . . . 65.9 t -126.44 117.91 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.649 0.738 . . . . 0.8 109.09 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 221' ' ' VAL . . . . . . . . . . . . . 31.3 m -140.92 165.11 20.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.516 -0.74 . . . . 0.87 109.512 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 222' ' ' ASP . . . . . 0.712 ' OD1' ' N ' ' D' ' 225' ' ' LYS . 6.6 p30 -94.24 167.02 11.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.493 -0.754 . . . . 1.0 109.305 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 223' ' ' VAL . . . . . . . . . . . . . 69.0 t -57.38 -44.73 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.049 -1.032 . . . . 0.92 110.429 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 224' ' ' ALA . . . . . 0.857 ' O ' HG22 ' D' ' 227' ' ' ILE . . . -62.79 -44.81 95.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.005 -1.06 . . . . 1.11 109.353 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 225' ' ' LYS . . . . . 0.712 ' N ' ' OD1' ' D' ' 222' ' ' ASP . 45.7 tttm -68.26 -35.06 77.32 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 120.863 -1.148 . . . . 1.14 109.58 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 226' ' ' MET . . . . . . . . . . . . . 10.3 tpt -62.22 -40.36 95.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.015 -1.053 . . . . 0.99 111.124 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 227' ' ' ILE . . . . . 0.857 HG22 ' O ' ' D' ' 224' ' ' ALA . 17.3 tt -60.85 -34.59 59.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.683 -0.858 . . . . 1.17 108.683 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 228' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.52 -38.9 62.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.802 -0.561 . . . . 1.53 110.913 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 229' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.22 -41.66 92.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.8 -1.185 . . . . 1.21 107.8 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 230' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' D' ' 230' ' ' TYR . 36.9 t80 -67.24 -32.07 72.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.08 -1.013 . . . . 1.25 109.788 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 231' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -72.77 6.8 2.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.055 -1.028 . . . . 1.48 110.113 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 232' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -110.35 117.69 50.77 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.134 -0.979 . . . . 1.54 109.366 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 233' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -64.97 0.5 2.51 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.608 1.539 . . . . 1.64 111.932 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 234' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -59.99 -24.56 64.55 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.056 -1.028 . . . . 1.56 108.8 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 235' ' ' TYR . . . . . 0.51 ' O ' ' HB2' ' D' ' 238' ' ' GLU . 81.1 m-85 -105.58 15.75 26.51 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.57 -0.852 . . . . 1.4 108.988 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 236' ' ' ALA . . . . . . . . . . . . . . . -54.74 135.79 46.84 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.055 -1.653 . . . . 1.51 109.655 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.61 -33.42 1.86 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.339 -1.504 . . . . 1.4 109.339 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 238' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' D' ' 235' ' ' TYR . 4.0 mm-40 -54.27 138.97 37.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.823 -1.398 . . . . 1.37 109.367 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 239' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -99.11 116.29 30.98 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.443 -0.947 . . . . 1.37 108.443 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 240' ' ' VAL . . . . . 0.584 HG21 ' SD ' ' D' ' 162' ' ' MET . 26.3 t -121.83 148.68 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.829 0.823 . . . . 0.99 110.492 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 241' ' ' MET . . . . . . . . . . . . . 13.7 ttm -102.7 134.81 45.47 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.008 -1.108 . . . . 0.76 108.008 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 242' ' ' LEU . . . . . 0.404 ' HB3' ' CE2' ' D' ' 244' ' ' PHE . 61.0 mt -102.0 127.24 48.96 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.949 0.88 . . . . 0.67 109.878 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 243' ' ' LEU . . . . . . . . . . . . . 97.5 mt -109.27 126.05 52.93 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.877 0.846 . . . . 0.41 109.155 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 244' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' D' ' 242' ' ' LEU . 77.6 m-85 -127.02 161.99 27.07 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.78 0.8 . . . . 0.5 109.4 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 245' ' ' THR . . . . . . . . . . . . . 69.4 p -109.44 -19.55 13.21 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.748 0.785 . . . . 0.38 109.012 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 246' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' D' ' 246' ' ' ASN . 17.2 p30 -151.01 141.73 14.84 Favored Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 119.935 -0.706 . . . . 0.54 109.912 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 247' ' ' PRO . . . . . 0.459 ' HG3' ' CE2' ' D' ' 291' ' ' PHE . 7.4 Cg_endo -60.71 -14.53 32.14 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.627 2.218 . . . . 0.57 112.185 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 248' ' ' THR . . . . . . . . . . . . . 96.1 m -65.14 -42.66 93.6 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.435 -0.95 . . . . 0.77 108.435 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 249' ' ' ASP . . . . . 0.429 ' O ' HD12 ' D' ' 253' ' ' LEU . 97.8 m-20 -67.33 -23.37 65.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.566 -0.709 . . . . 0.64 109.85 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 250' ' ' VAL . . . . . . . . . . . . . 98.4 t -73.97 -43.69 51.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.589 -1.319 . . . . 0.68 109.697 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 251' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -62.37 -35.0 77.79 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.229 -0.988 . . . . 0.93 108.491 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 252' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -62.34 -44.16 97.13 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.335 -0.853 . . . . 1.01 110.193 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 253' ' ' LEU . . . . . 0.429 HD12 ' O ' ' D' ' 249' ' ' ASP . 1.2 mp -64.08 -40.32 96.0 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.881 -1.528 . . . . 0.93 108.867 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 254' ' ' VAL . . . . . 0.574 ' CG2' HD12 ' D' ' 260' ' ' ILE . 70.8 t -60.78 -44.59 97.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.715 -1.24 . . . . 1.01 108.905 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 255' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.37 -30.86 69.84 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.899 -1.126 . . . . 1.17 109.906 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 256' ' ' GLY . . . . . . . . . . . . . . . -74.37 2.91 43.41 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.544 -1.422 . . . . 1.2 109.544 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 257' ' ' GLY . . . . . . . . . . . . . . . 94.46 15.81 45.55 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.599 -1.401 . . . . 1.16 109.599 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 258' ' ' VAL . . . . . . . . . . . . . 95.6 t -77.91 139.7 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 106.886 -1.524 . . . . 1.03 106.886 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 259' ' ' LYS . . . . . 0.701 ' NZ ' ' ND2' ' D' ' 159' ' ' ASN . 17.7 tttt -98.97 123.74 43.46 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.972 -1.08 . . . . 1.2 110.912 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 260' ' ' ILE . . . . . 0.574 HD12 ' CG2' ' D' ' 254' ' ' VAL . 98.1 mt -130.09 125.42 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.537 -0.727 . . . . 0.85 109.15 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 261' ' ' THR . . . . . . . . . . . . . 64.8 p -89.26 -31.54 17.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.699 -1.251 . . . . 0.93 110.202 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 262' ' ' SER . . . . . . . . . . . . . 15.7 m -159.06 153.43 24.02 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.168 -0.957 . . . . 0.79 110.071 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 263' ' ' VAL . . . . . . . . . . . . . 51.2 t -122.65 134.51 65.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 108.615 -0.883 . . . . 0.59 108.615 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 264' ' ' ASN . . . . . 0.471 ' ND2' ' CH2' ' D' ' 182' ' ' TRP . 33.5 t30 -108.51 128.19 54.59 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.543 0.687 . . . . 0.63 110.609 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 265' ' ' VAL . . . . . 0.462 HG21 ' SD ' ' D' ' 314' ' ' MET . 3.2 t -90.76 108.39 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.475 0.655 . . . . 0.59 109.69 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 266' ' ' GLY . . . . . . . . . . . . . . . -80.78 -53.82 3.87 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.184 -1.166 . . . . 0.62 110.184 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 267' ' ' GLY . . . . . . . . . . . . . . . -172.61 152.99 17.82 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 118.715 -1.707 . . . . 0.55 111.462 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 268' ' ' MET . . . . . 0.436 ' HB2' ' H ' ' D' ' 282' ' ' SER . 97.0 mtp -143.12 118.09 10.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.533 -0.981 . . . . 0.71 110.392 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 269' ' ' ALA . . . . . . . . . . . . . . . -51.21 128.2 21.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.421 -0.799 . . . . 0.77 109.489 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 270' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' D' ' 271' ' ' ARG . 16.3 t80 -69.79 161.89 28.95 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.117 -0.99 . . . . 1.2 109.672 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 271' ' ' ARG . . . . . 0.54 ' N ' ' CD1' ' D' ' 270' ' ' PHE . 2.3 mmt180 -160.72 158.56 28.88 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.043 -1.036 . . . . 1.15 109.69 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 272' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -66.46 138.22 57.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.93 -1.107 . . . . 1.39 110.366 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 273' ' ' GLY . . . . . . . . . . . . . . . 95.54 -12.29 67.82 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.721 -1.752 . . . . 1.27 108.721 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 274' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -101.72 163.46 12.25 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.434 -1.039 . . . . 1.19 109.489 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 275' ' ' THR . . . . . 0.564 HG21 HG21 ' D' ' 321' ' ' ILE . 20.8 m -110.01 135.77 50.33 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.686 -0.857 . . . . 1.22 108.686 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 276' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -81.97 119.37 23.88 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.225 -0.922 . . . . 1.25 110.146 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 277' ' ' VAL . . . . . 0.507 HG12 ' CD1' ' D' ' 321' ' ' ILE . 27.4 m -99.18 -28.41 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.433 -0.792 . . . . 1.06 109.622 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 278' ' ' ASN . . . . . 0.468 ' OD1' ' N ' ' D' ' 279' ' ' ASN . 10.4 t-20 -135.85 -177.17 4.57 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.862 0.839 . . . . 1.05 109.659 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 279' ' ' ASN . . . . . 0.468 ' N ' ' OD1' ' D' ' 278' ' ' ASN . 10.3 m120 -57.03 -29.69 63.59 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.663 -0.648 . . . . 1.23 110.836 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 280' ' ' ALA . . . . . . . . . . . . . . . -148.17 27.07 0.96 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.773 -1.205 . . . . 0.95 109.548 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 281' ' ' VAL . . . . . 0.491 ' O ' HG22 ' D' ' 277' ' ' VAL . 60.5 t -119.05 121.79 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.868 -0.733 . . . . 0.88 109.755 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 282' ' ' SER . . . . . 0.436 ' H ' ' HB2' ' D' ' 268' ' ' MET . 29.1 m -118.52 147.62 43.47 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.436 0.636 . . . . 0.92 110.022 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 283' ' ' VAL . . . . . . . . . . . . . 16.4 m -135.18 142.77 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 122.389 1.09 . . . . 0.96 110.52 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 284' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' D' ' 287' ' ' ASP . 44.1 p-10 -110.73 171.62 7.36 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.971 -1.492 . . . . 0.96 106.971 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 285' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -56.18 -24.03 38.96 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 120.793 -1.192 . . . . 1.33 109.669 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 286' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -79.73 -43.38 22.73 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.948 -1.095 . . . . 0.96 110.054 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 287' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' D' ' 284' ' ' ASP . 93.1 m-20 -64.2 -42.24 96.72 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.145 -0.972 . . . . 0.8 109.136 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 288' ' ' ILE . . . . . . . . . . . . . 88.9 mt -62.41 -45.88 97.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.247 -0.908 . . . . 1.0 109.462 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 289' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -57.3 -39.43 75.75 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.167 -0.958 . . . . 1.15 110.435 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.58 -40.98 84.83 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.815 -1.178 . . . . 0.8 109.881 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 291' ' ' PHE . . . . . 0.459 ' CE2' ' HG3' ' D' ' 247' ' ' PRO . 40.3 m-85 -63.83 -39.22 93.71 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.375 -0.828 . . . . 0.75 109.666 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 292' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -63.95 -39.39 94.04 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.29 -0.964 . . . . 1.11 110.197 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 293' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -65.97 -41.49 91.13 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.836 -1.165 . . . . 1.07 109.486 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 294' ' ' LEU . . . . . . . . . . . . . 77.8 mt -62.21 -43.17 99.44 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.984 -1.072 . . . . 0.8 108.832 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 295' ' ' ASN . . . . . 0.584 HD22 ' HG3' ' D' ' 315' ' ' MET . 40.4 t-20 -63.96 -40.13 95.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.117 -0.989 . . . . 0.9 109.881 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 296' ' ' ALA . . . . . . . . . . . . . . . -62.62 -21.35 65.6 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.837 -1.164 . . . . 1.01 109.256 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 297' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -90.22 9.02 30.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.847 -1.158 . . . . 1.06 109.848 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 298' ' ' GLY . . . . . . . . . . . . . . . 82.28 11.34 82.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.884 -1.286 . . . . 0.93 109.884 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 299' ' ' ILE . . . . . . . . . . . . . 97.7 mt -84.62 134.66 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.938 -1.33 . . . . 0.84 109.107 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 300' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -82.1 141.78 32.85 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.473 -0.891 . . . . 0.95 110.664 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 301' ' ' LEU . . . . . . . . . . . . . 67.1 mt -123.07 111.27 16.36 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.328 -0.619 . . . . 0.74 109.328 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 302' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -115.66 140.09 49.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.395 -0.815 . . . . 0.87 110.162 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 303' ' ' VAL . . . . . 0.615 ' CG2' ' SD ' ' D' ' 314' ' ' MET . 52.6 t -112.02 124.92 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.751 -0.833 . . . . 0.84 108.751 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 304' ' ' ARG . . . . . 0.464 ' HE ' ' CG ' ' D' ' 264' ' ' ASN . 33.4 ptt180 -165.14 137.82 4.45 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.621 -0.832 . . . . 0.88 110.388 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 305' ' ' LYS . . . . . 0.496 ' CD ' ' H ' ' D' ' 305' ' ' LYS . 0.0 OUTLIER -80.97 -45.41 16.69 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.6 -0.84 . . . . 0.97 109.655 179.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 306' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.23 153.92 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.117 -0.989 . . . . 1.06 108.785 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 307' ' ' SER . . . . . . . . . . . . . 83.6 p -64.5 -16.37 62.41 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.937 -1.102 . . . . 1.12 109.511 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 308' ' ' THR . . . . . 0.626 HG21 HH12 ' D' ' 181' ' ' ARG . 43.4 p -86.03 -8.97 57.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.06 -1.025 . . . . 1.28 110.116 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 309' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -92.44 152.68 42.43 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.004 -1.06 . . . . 1.2 109.912 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 310' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -55.27 139.09 80.94 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.915 1.743 . . . . 1.29 111.765 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 311' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -84.15 132.68 34.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.112 -0.992 . . . . 1.08 109.832 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 312' ' ' LEU . . . . . . . . . . . . . 93.2 mt -117.31 154.91 30.42 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 1.13 108.373 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 313' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -91.47 130.59 37.28 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.108 -0.995 . . . . 1.04 109.78 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 314' ' ' MET . . . . . 0.615 ' SD ' ' CG2' ' D' ' 303' ' ' VAL . 8.2 tpt -56.55 -44.11 80.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.592 -0.693 . . . . 0.88 109.63 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 315' ' ' MET . . . . . 0.584 ' HG3' HD22 ' D' ' 295' ' ' ASN . 95.8 mmm -61.1 -40.51 94.01 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.553 -0.717 . . . . 1.02 110.235 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 316' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -61.76 -44.12 97.51 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.341 -0.849 . . . . 1.13 109.758 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 317' ' ' LEU . . . . . . . . . . . . . 92.9 mt -66.47 -41.93 88.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -0.885 . . . . 1.1 109.947 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 318' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.42 -24.32 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 1.13 110.024 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 319' ' ' SER . . . . . 0.477 ' O ' ' C ' ' D' ' 323' ' ' LYS . 0.9 OUTLIER -72.77 -31.56 64.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 1.29 109.594 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 320' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -84.08 -2.56 56.94 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.844 -1.142 . . . . 1.38 109.244 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 321' ' ' ILE . . . . . 0.564 HG21 HG21 ' D' ' 275' ' ' THR . 93.2 mt -113.84 -58.63 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.022 -1.103 . . . . 1.36 108.022 177.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 322' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' D' ' 323' ' ' LYS . 12.1 t0 -94.91 85.04 4.28 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.284 -1.747 . . . . 1.29 106.284 178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 323' ' ' LYS . . . . . 1.272 ' NZ ' ' HA ' ' D' ' 323' ' ' LYS . 0.0 OUTLIER . . . . . 1 C--O 1.524 15.537 0 CA-C-O 126.343 2.973 . . . . 1.54 109.42 -177.659 . . . . . . . . 3 3 . 1 stop_ save_